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 Synthesis and NMR Structure Determination of Bis-Amino Acid Oligomers 
 Paul M. Morgan, PhD 
University of Pittsburgh, 2007
 
 I present the complete synthesis of 3 bis-amino acid monomers.  The pro3 class monomer 
was designed to create a sharp turn in bis-peptide oligomeric sequences.  The pro3(2S4S) 
monomer was synthesized, but had an unexpected tendency to epimerize when incorporated into 
an oligomer.  The synthesis of two pip5 class monomers was complete.   
I present the first use of residual dipolar couplings (RDCs) in the solution structure 
determination of a bis-peptide oligomer.  This technique allows the determination of bond 
orientations with respect to the magnetic field of a nuclear magnetic resonance (NMR) 
spectrometer.  I showed that the information gained from the measurement of RDCs can be used 
to filter a library conformational models to select the best fit model to the RDC data.  The best fit 
model was found to be the lowest energy conformation of the bis-peptide oligomer.  
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1.0  INTRODUCTION 
Nature’s primary tools are proteins.  These nanoscale (on the order of 10-9 meters in size) 
machines serve such diverse purposes within organisms as energy transduction and utilization, 
motion and catalysis.  Currently no technology outside of the biological realm has been 
developed to work as efficiently and diversely on the nanoscale as proteins.   
The ability for science to understand how to mimic the capabilities of proteins is 
hampered by the complexity of the protein folding problem. Proteins are chains of amino acids 
that undergo a complex and poorly understood folding process in order to attain a well defined 
and functional three-dimensional structure. Folded proteins place multiple functional groups in 
precise three-dimensional arrangements and it is such precise location of functional groups that 
enables proteins to carry out their molecular recognition and catalytic functions.  A synthetic 
approach to create macromolecules that could mimic this placement of functional groups but 
would avoid the complex process of folding would be a great advance towards the creation of 
designed nanostructured devices and would allow us to learn a great deal about the relationship 
between function and structure in macromolecules1.   
1.1 FOLDAMERS 
Several groups have developed unnatural oligomers termed “Foldamers” that adopt well 
defined secondary structures with very short sequences. Gellman has coined the term foldamer 
“to describe any polymer with a strong tendency to adopt a specific compact conformation”2.  A 
goal of foldamer research efforts is the development of molecules which can adopt designed 
three-dimensional structures and perform designed functions3.   
 1 
Diverse foldamers have been developed with a wide range of monomer structures and 
non-covalent interactions employed to achieve the designed oligomer shape (Figure 1)3.  While 
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From top left: Seebach (A) and Gellman’s (B) β-peptide monomers, Lehn’s pyridine-pyrimidine oligomers (C), 
Moore’s phenylene ethynylene oligomers (D), and Nieslen’s peptide nucleic acids (PNA’s) (E).  Each of these 
monomer types forms a helical structure.  Copied from ref. 3. 
Figure 1.  Sample of Diverse Foldamer Monomer Structures 
 
many unnatural oligomers adopt well defined helical secondary structures, it remains outside of 
our ability to rationally design foldamers that adopt well defined tertiary structure (Figure 2). 
 
1.2 BIS-PEPTIDE APPROACH TO MACROMOLECULAR SYNTHESIS  
In the bis-peptide approach to macromolecular design developed in our lab4-8, we avoid 
the use of non-covalent interactions to achieve three-dimensional structure and instead create  
 
 2 
 
Common structures adopted by foldamers.  Copied from reference 3. 
Figure 2. Range of Common Shapes Seen in Foldamers 
 
structure by coupling cyclic monomers to each other through pairs of bonds to create spiro-
ladder oligomers (Figure 3a). 
In our bis-peptide approach, monomers contain two amino acid functionalities displayed 
on a cyclic framework (Figure 4).  We connect the monomers together through pairs of amide 
bonds forming a 2,5-diketopiperazine linkage as indicated in red in Figure 3a.  The 
diketopiperazine linked oligomers have limited conformational freedom as there are no freely 
rotating bonds in the oligomer backbone. The three-dimensional shape of bis-peptide oligomers 
is defined by synthetically controlled features including the structures of the monomer rings, the 
stereochemical configuration of the stereocenters within each monomer, and the monomer 
sequence within the oligomer.   
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Two bis peptide oligomers shown at top as chemical structures.  The solved solution phase NMR structures 
(Chapter 4) of these compounds. 
Figure 3. Example of Two Bis-Peptide Trimers 
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Figure 4. Currently Developed Bis Amino Acid Monomers 
 
 4 
In working to expand our ability to synthesize more complex bis-peptide oligomers, I 
developed a new class of bis-amino acid monomer that we called the “pro3” monomer class (cf 
Chapter 2) and I also worked on developing the “pip4” monomer class (cf Chapter 3).  In order 
to better determine the three-dimensional structures of bis-peptides I developed the use of 
residual dipolar couplings as additional NMR constraints for NMR solution structure 
determination (cf Chapter 4).  
 5 
2.0  3-HYDROXY-PROLINE DERIVED MONOMER SYNTHESIS 
To develop bis-peptide oliogmers capable of carrying out molecular recognition and 
biomimetic catalysis, the development of bis-amino acid monomers capable of producing tight 
turns within these macromolecules is required.  We designed a 3-hydroxy-proline derived 
monomer class (pro3 class) that, based on modeling in the computer program MOE9 with the 
AMBER 94 Force Field10, would provide such a turn (Figure 5).  This chapter details my 
synthesis of two versions of the pro3 monomer and my work to incorporate it into a short 
oligomer.  I found that both version of the pro3 monomer performed poorly in solid phase 
peptide synthesis with other bis-amino acid monomers and once incorporated into an oligomer, I 
found that the pro3 monomer had an unexpected tendency to spontaneously epimerize at the C2 
position. 
 
Stereoview of a sequence of 5 pro3 class monomers sequence Gly-pro3(2S3S)-pro3(2S3S)-pro3(2S3S)-
pro3(2S3R)-pro3(2S3S)-pro3(2R3S)-Gly that creates a tightly turned oligomer. 
Figure 5. Curved Structure Containing pro3 Class Monomers 
 6 
2.1 SYNTHETIC OUTLINE UTILIZING THE BUCHERER-BERGS REACTION 
The original retrosynthetic analysis of the pro3 class monomer synthesis involved the 
installation of a second α−amino acid functionality on C3 of the pyrrolidine ring through a 
Bucherer-Bergs11,12 reaction from the ketone 3 (Scheme 1).  β−Ketoester 3 could only be realized 
in a stereopure manner when the risk of deprotonation at the proline α−carbon was effectively 
eliminated.  We envisioned that a bulky 9-phenyl-9-fluorenyl (PhF)13 protecting group, 6, on the 
secondary amine of 3 would protect the α-proton from epimerization.  After the PhF protection, 
oxidation could be performed to yield the β-ketoester 3 with reduced risk of epimerization13,14.  
1
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Scheme 1.  Retrosynthesis of Monomer via Bucherer-Bergs Reaction. 
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citric acid/MeOH. c.) TPAP, NMO, DCM, 4A M.S d.) KCN, (NH4)CO3, DMF, H2O, 60oC 
Scheme 2. Synthesis of the β−Ketoester 
2.2 RESULTS OF THE BUCHERER-BERGS SYNTHETIC APPROACH 
Formation of the methyl ester hydrochloride salt 7 of (2S,3S)-3-hydroxy–proline, 5, was 
accomplished in quantitative yield by Fischer esterification in methanolic hydrogen chloride 
(Scheme 2).   
We were able to protect the secondary nitrogen atom of 7 as the 9-phenyl-fluorenyl 
amine, 4, in a one pot, four step process.  The amine and hydroxyl groups of 7 were first masked 
with two equivalents of chlorotrimethylsilane (TMSCl), and the trimethylsilyl (TMS) group on 
the amine was selectively removed with 0.9 equivalents of methanol.  The amine was then 
reacted with 9-bromo-9-phenyl-fluorene15 in the presence of lead nitrate to install the PhF 
protecting group.  A solution of 10% citric acid in methanol was used to remove the 
trimethylsilyl group from the alcohol to form 4 in 68% overall yield from 7. 
 
 8 
NO
PhF
CO2Me
KCN, (NH4)2CO3,
DMF, H2O, 60oC
H
N
OH
CO2Me
93
+
8  
Figure 6. Bucherer-Bergs Reaction Products 
 
Subsequently, 4 was converted to the β-ketoester 3 by oxidation with TPAP 
(tetrapropylammonium perruthenate) and NMO (4-methyl-morpholine N-oxide) in 90% yield.  
The ketone 3 was subjected to the conditions of the Bucherer-Bergs reaction (KCN, (NH4)2CO3, 
DMF (N,N-dimethylformamide), H2O, 60oC), but no spirohydantoin 2 could be isolated from the 
reaction.  The isolated products were 9-phenyl-9H-fluorene 8 and 3-hyroxy-pyrrole-2-methyl 
ester, 9 (Figure 6). 
Pyrrolidine ring aromatization has been observed by Marcotte and Lubell16 in 9-phenyl-
fluoren-9-yl-3-oxo-proline derivatives, such as 3, but the exact mechanism has not been 
determined.  An E1Cb mechanism has been proposed for the transformation and appears in 
Figure 716.   
2.3 SYNTHESIS BASED ON A MODIFIED COREY-LINK REACTION 
A modified Corey-Link17,18 reaction was next employed to install the amino acid 
functionality at C3 of the pyrrolidine ring.  This approach (Scheme 3) allowed the synthesis of a 
pro3 monomer, with the second amine functionality masked as an azide 10. 
The conversion of the ketone 3 into the trichlorocarbinol diastereomers 11a and 11b was 
accomplished by deprotonation of chloroform at -78oC in THF with LHMDS (lithium  
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Figure 7. Pyrrole Formation Mechanism from PhF Pyrrolidine 
 
hexamethyldisilazide) resulting in attack on the ketone by the trichloromethyl anion  (71.0% 
overall yield).  The trichloromethyl anion was observed to favor addition from the si face of the 
ketone over the re face (Figure 8) in a 15:1 ratio as determined by HPLC analysis of the 
quenched reaction mixture.  The preference for formation of 11a over 11b was due to the 
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Scheme 3. Retrosynthesis via the Modified Corey-Link Reaction 
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Figure 8. Diastereomeric Preference of the Trichloromethyl Anion Addition 
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Arrows indicate major cross peaks of note. 
Figure 9. 500 MHz ROESy Spectrum of Major Diastereomer of Trichlorocarbinol 11a 
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Figure 10. Stereoview of X-ray Diffraction Crystal Structure of 11a 
 
presence of the methyl ester at C2.  Compound 11a was purified by column chromatography 
followed by crystallization from ethyl acetate and hexanes. 
Assignment of the stereochemistry at the C3 center of the major trichlorocarbinol product 
was initially performed using ROESY NMR spectroscopy in deuterated chloroform.  In the 
ROESY spectrum (Figure 9), strong correlations were observed between the alcohol proton and 
one of each of the geminal hydrogen atoms on the γ- and δ-carbons of the pyrrolidine ring, while 
the C2 hydrogen atom displayed strong correlations in the spectrum with the opposite geminal 
hydrogen atom on each of these carbon atoms.  This evidence led to our conclusion that the 
alcohol and the C2 hydrogen atom were on opposite faces of the pyrrolidine ring in the major 
diastereomer.  This stereochemical relationship was confirmed by the X-ray diffraction crystal 
structure obtained from the major diastereomer (Figure 10).  
The formation of the dimethyl ester 12 from trichlorocarbinol 11a was accomplished 
using sodium methoxide in methanol solvent (83 % yield), while conversion of 11a to the α- 
azidoacid 13 (yield 95%) was performed with sodium hydroxide in 3:2 dioxane: water (Scheme 
4). 
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a.) NaOMe, NaN3, MeOH, RT  b.) NaOH, NaN3, 18-crown-6, dioxane, water, RT 
Scheme 4. Conversion of the Trichlorocarbinol to α-Azido Carbonyl Compounds 
 12 
  
The mechanism proposed for conversion of the trichlorocarbinol 11a into 12 and 13 was 
put forth by Corey and Link17,18 (Figure 11).  Initiation of the reaction was accomplished by 
deprotonation of the C3 alcohol with either sodium methoxide or sodium hydroxide.  The C3 
alkoxide performed an SN2 attack on the trichloromethyl group to form a dichloroepoxide 
intermediate.  Opening of the dichloroepoxide at C3 of the pyrrolidine ring with azide ion 
resulted in the formation of an acid chloride.  The resultant acid chloride further reacted with 
either methanol or water solvent to yield either 12 (83.7 % yield) or 13 (95.2% yield) 
respectively. 
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Figure 11. Corey-Link Reaction Mechanism 
2.4 DETERMINATION OF THE PURITY OF THE MONOMER 
The stereochemical purity of acid 13 was determined by formation of an amide bond to 
samples of both (R)- and (S)-phenylethylamine using HATU (O-(7-azabenzotriazol-1-yl)-
N,N,N’,N’-tetramethyluronium hexafluorophosphate) in 20% dichloromethane (DCM) in DMF 
(N,N-dimethylformamide).  The reaction provided diastereomeric derivatives of 13 that could be 
differentiated using reverse phase HPLC (Figure 12).  In the chromatogram, trace R refers to 13 
reacted with (R)-phenylethylamine, trace S refers to the product of the reaction with the  (S) 
enantiomer of the amine, and trace R+S is a mixture of samples from the (S)- and (R)-
phenylethylamine products. The products of both the (R) and (S) enantiomers yielded expected 
m/z ([M+H]+) = 558 by LCMS.  The results reveal that the product 13 of the Corey-Link reaction 
can be isolated as a single stereoisomer with greater than 99% purity. 
 13 
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HPLC traces of 13 coupled to either (R)- or (S)-phenylethylamine and a mixture of both products.  Each sample 
(5μL) was introduced to the C18 column in methanol at room temperature.  The solvent was run at a gradient of 50% 
to 80% over 30 minutes of acetonitrile in H2O with 0.1% TFA added. The milliabsorbance of the solution was 
measured at 274 nm 
Figure 12. HPLC Trace of Products of (R) and (S)-Phenylethylamine Coupling 
2.5 SOLUTION PHASE COUPLING OF MONOMERS 
 Solid phase peptide synthesis techniques were employed in an attempt to form a short 
oligomer containing two monomers of 13.  The formation of the sequence Tyr-13-13-Ala 
(Scheme 5) was attempted on a resin with an MBHA (methylbenzhydrylamine) linker and 
another resin with a hydrazine linker. The resins were treated to cleave the sequence from the 
linkers, and the resulting products were analyzed by LC/MS.  The mass spectrum of each 
cleavage solution contained a component consistent with amide bond formation between tyrosine  
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DMF in DCM.  Reactions were performed on both MBHA and Hydrazino likers on a polystyrene bead. 
Scheme 5. Attempt to Form a Tyr-13-13-Ala Sequence on Solid Phase  
 
and 13, however the mass spectrometry data showed no compound with a mass corresponding to 
the incorporation of a second monomer of 13.  
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Scheme 6. Dimer Formation with the Secondary Amine in Solution Phase 
 
We next attempted the solution phase formation of an amide bond between the acid in 13 
and the pyrrolidine nitrogen atom of another monomer, 14 (Scheme 6).  The pyrrolidine nitrogen 
atom in dimethyl ester 12 was deprotected using 2.5% TFA (trifluoroacetic acid) in DCM to 
yield 14 in 95% yield.  The coupling of 14 and 13 was attempted using HOBt (hydroxyl 
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benztriazole) and DCC (dicyclohexylcarbodiimide) in 4:1 THF (tetrahydrofuran):DCM (Scheme 
6).  From this reaction 13 and its hydroxyl benztriazole (OBt) ester 16 were isolated after 
purification by silica gel chromatography.  The isolation of the 16 suggested that the coupling 
had failed due to steric crowding at the C3 acid of 13 as the OBt esters are considered to be 
highly electrophilic esters.  Compound 16 partially hydrolyzed over two days back into the acid 
13 upon exposure to ambient conditions. 
Solution phase formation of dimer 15 with coupling agents TFFH 
(tetrafluoroformamidinium hexalfluorophosphate), PyBrop (Bromo-tris-pyrrolidino-
phosphonium hexafluorophosphate) or HATU demonstrated some amide bond formation 
between 13 and 14, but yields of 15 were low (Table 1).  The best yield of 15 (yield 36.4%) 
occurred using HATU in 20% DCM in DMF incubated at room temperature for 24 hours. The 
isolated product 15 was characterized by high-resolution mass spectrometry, but attempts to 
obtain a 1H NMR spectrum free from rotational isomers were unsuccessful at temperatures up to 
and including 360 K. 
 
Table 1. Conditions and Yields of Coupling Reactions to Form 15 
Coupling 
Reagent 
Equivalents 
of 13 
Equivalents 
of 14 
Solvent Reaction 
Time (hour) 
Yield of 15 
HATU 1.0 1.0 20% DMF in 
DCM 
24 34% 
PyBroP 1.25 1.0 DCM 24 27% 
HATU 1.5 1.0 DMF 24 9% 
TFFH 1.26 1.0 DCM 24 0% 
HOBt, DCC 1.26 1.0 4:1 
THF:DCM 
18 0% 
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2.6 SYNTHESIS OF THE MONOMER WITH A CARBOXYLIC ACID AT C2 
Due to the low yields of amide bond formation with the C3 acid in 13, the synthesis of 
the pro3 class of monomers was modified to allow the installation of a carboxylic acid at C2 of 
the pyrrolidine ring (Scheme 7) and conversion of the C3 acid to a methyl ester.  The sequence 
utilized a Corey-Link reaction to install the C3 masked α-amino acid functional group.  Starting 
from (2S,3S)-3-hydroxy-proline 5, Fischer esterification formed the allyl ester 17 in quantitative 
yield.   Protection of the amine of 17 with 9-bromo-9-phenyl-fluorene yielded 18 (75% yield), 
which was converted to the β-ketoester 19 by Swern oxidation (80% yield).  The formation of 20 
(61% yield) was accomplished at -78oC by allowing ketone 19 to react with an excess of  
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a.) HCl (g), allyl alcohol b.) i) 2 eq. TMSCl, DIPEA, DCM ii.) 0.9 eq MeOH iii.) PhFBr, Pb(NO3)2, DIPEA iv.) 10% citric acid in MeOH c.) i.) 
DMSO, SOCl2, DCM, -78oC. (5 min). ii.) TEA (-78oC to 25oC.)  d.) Chloroform, LHMDS, THF, -78oC e.) NaN3, DBU, 18-crown-6, MeOH f.) i.) 
Zn, HOAc, THF ii.) FmocCl, DIPEA, DCM g.) i.) TFA, MeOH, DCM ii.) Boc2O, DIPEA, DCM h.) Pd(PPh3)4, morpholine, THF 
Scheme 7. Synthesis of the Monomer 24 
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 chloroform and one equivalent of LHMDS (lithium hexamethyldisilazide).  Addition of the 
trichloromethyl carbanion hypothesized to occur from less hindered face of ketone 19, and the 
stereochemistry of 20 was inferred from the major trichlorocarbinol diastereomer 11a.  No 
amount of the trichlorocarbinol diastereomer corresponding to addition to the opposite face of 19 
could be observed by NMR in either the crude reaction mixture or the purified product.   
The conversion of the trichlorocarbinol 20 into the α-azido ester 21 was accomplished 
using DBU (1,8-diazabicyclo[5.4.0]undec7-ene), sodium azide and 18-crown-6 (80% yield) in 
methanol15.  The reduction of the azide 21 to the amine using Zn/acetic acid followed by Fmoc 
((9H-fluoren-9-yl) methyl carbamate) protection gave 22 in 96% yield over two steps.  The 
removal of the PhF protecting group with TFA, was followed by Boc protection with di-t-butyl 
carbonate of the amine to give 23 (93% yield).  Deprotection of the allyl ester of 23 was 
accomplished using Pd(PPh3)4 and morpholine to provide the orthogonally protected bis-amino 
acid 24 (93% yield) in an overall yield of 24% from 5. 
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Scheme 8. Solid Phase Formation of Tyr-24-24 Sequence 
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Compound 24 was used in an attempt to form the sequence Tyr-24-24 by solid phase 
peptide synthesis (Scheme 8).  The formations of an amide bond between 24 and resin bound 
tyrosine using HATU preactivation occurred in quantitative yield.  We subsequently encountered 
difficulty incorporating a second residue of 24 into the resin bound sequence to form 25 (Scheme 
8). Our attempts to form this amide bond included the use of HATU, PyBrop, and TFFH 
activating reagents, but all reagents provided yields of 25 below 60% as measured by Fmoc 
release from the resin (Table 2).  The quantity of Fmoc released from the resin was calculated 
from the absorbance of the piperidine-fulvene adduct in the 20% DMF in DCM deprotection 
solution as measured at λ = 301 nm.  
 
Table 2. Conditions and Yields of Solid Phase Formation of Tyr-24-24 Sequence 
 
Coupling Reagent Time of Reaction Number of Coupling 
Reaction Repeats 
Yield of 25 
2 eq. HATU 2 hours 2 42% 
2 eq. TFFH 2 hours 2 31% 
2 eq. PyBroP 2 hours 2 28% 
2 eq. HATU 2 hours 1 15% 
2 eq. HATU 4 hours 2 55% 
 
 
These unexpectedly low yields lead us to probe the effect of reaction time on the 
formation of 25.  Reaction time was varied using 2 equivalents of HATU preactivated monomer 
24 and the yields of 25 are shown in Table 2.  A reaction time of 4 hours gave the best yield 
(55%), but only a 13% improvement in yield of 25 over the normal 2 hour coupling time.  Since  
only a modest increase in yield was noted upon extended reaction time further increases in 
reaction time were not investigated. 
The formation of a Tyr-24-pro4(2S4S) sequence was attempted to determine if 
quantitative amide bond formation was possible with other bis-amino acids.  We encountered 
difficulty in the formation of the amide bond between resin bound 24 and the pro4(2S4S) 
monomer to form 26 (Scheme 9).  The formation of 26 was attempted with coupling agents 
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HATU, TFFH and PyBrop preactivation with HATU providing the best yield.  The yields of 26 
for the various reagents are shown in Table 3, but no reagent was able to yield more than 60% of 
26. 
 
 
Table 3 Conditions and Yields of Solid Phase Formation of  Tyr-24-pro4(2S4S) Sequence 
Coupling Reagent Time of Reaction Number of Coupling 
Reaction Repeats 
Yield of 26 
HATU 2 hours 2 60% 
TFFH 2 hours 2 20% 
PyBroP 2 hours 2 35% 
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Scheme 9. Solid Phase Formation of Tyr-24-pro4(2S4S) Sequence 
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2.7 EPIMERIZATION OF THE PRO3(2S,3S) MONOMER WITHIN A BIS-PEPTIDE 
While studying the coupling yields of 24, the diketopiperazine linked sequence Tyr-24-
pro4-24-Gly, 27 (Figure 13) was formed by SPPS albeit in low yields. An attempt to determine 
the solution phase NMR structure of 27 at pH 3.5 in water/10% D2O ammonium acetate-
d7/acetic acid-d4 buffer was undertaken. 
HN
HN
N
O
HN
NH2
O
HO
O
O
N
H
N
O
O
NH
HN
O
O
27
 
Figure 13. Structure of the Tyr-24-pro4-24-Gly Diketopiperazine Linked Oligomer 
 
A one-dimensional 1H NMR spectrum was taken prior to further two-dimensional NMR 
spectroscopic experiments.  These two-dimensional NMR experiments covered a 48 hour time 
period.  After 48 hours a second one-dimensional 1H NMR spectrum was taken.  The sample was 
noted to have multiple new resonances present in the second one-dimensional 1H NMR 
spectrum. 
 Prior to initiation of the NMR experiments, a C18 reverse phase chromatogram of the 
NMR sample was obtained.  This sample showed only one compound with an elution time of 
17.1 minutes during a 30 minute runtime (0-25% gradient of acetonitrile in water with 0.1% TFA 
added) as detected at both 220 nm and 274 nm wavelengths by UV/Vis absorbance.  After the 48 
hours of NMR experimentation, the NMR sample was reinjected to obtain a second C18 reverse 
phase chromatogram.   The later injection was found to contain two compounds: one eluting at 
17.1 minutes and another eluting at 17.8 minutes (30 minute runtime, 0-25% gradient of 
acetonitrile in water with 0.1% TFA added). 
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Graph A shows the HPLC traces at 1 day (red trace) and 4 days (black trace) of a sample of 27 incubated in D2O at pD 3.5.  Graph B shows epi-
27 under the same conditions at 1 day (red trace) and 4 days (black trace).  Each run was detected at λ=220nm and λ=274 nm by UV/Vis 
absorbance during a 30 minute runtime with a gradient of 0-25% acetonitrile in water with 0.1% TFA added. 
Figure 14. RP-HPLC Chromatograms of the Epimerization of 27 
 
 22 
Each of the compounds in the NMR sample had an m/z [(M+H)] = 652, which 
corresponded to the molecular mass of 27 + H.  This suggested that 27 was epimerizing to form 
at least one new compound with a different retention time:  27 eluting at 17.1 minutes and 
Compound A eluting at 17.8 minutes.   
A new sample of 27 was synthesized, purified and allowed to incubate in pH 3.5 acetate 
buffered water, and monitored by HPLC for one week.  After one week two compounds 
corresponding in retention time to 27 and Compound A of the NMR sample mentioned above 
were contained in the sample.  The compounds were separated by RP-HPLC and each was 
placed in D2O (pD 3.5 acetate-d3 buffer).  A sample of each compound dissolved in the acetate 
buffered D2O was injected separately into an analytical C18 reverse phase liquid chromatography 
column and eluted on a 30 minute gradient of 0-25% acetonitrile in water with 0.1% TFA added.  
Repeated injections were performed at 24 hour intervals up to 96 hours after the samples were 
placed in the acetate buffer. 
In Figure 14a, the C18 reverse phase chromatogram of the sample containing 27 in acetate 
buffered D2O after 24 hours is shown in black, and the chromatogram shown in red was 
performed on the same solution at 96 hours.  The 96 hour chromatogram shows an increase in 
the amount of Compound A, and the mass spectrum of Compound A shows an increase in 
molecular mass of one Dalton over 27.  This increase in molecular mass is consistent with the 
incorporation of deuterium into Compound A upon conversion from 27. 
Figure 14b shows the C18 reverse phase chromatogram at 24 hours (red trace) and 96 
hours (black trace) of the acetate buffered sample which originally contained Compound A.  The 
formation 27 can be noted in the 96 hour sample.  In this sample, the mass spectrum of 27 
showed a one Dalton increase in molecular mass over Compound a, which again was consistent 
with incorporation of deuterium.  The chromatograms in Figure 14 were evidence of the 
epimerization of 27, with Compound B representing an epimeric form of 27.   
Sequences involving pro4 monomers and tyrosine had previously been formed and 
studied at similar pH  levels and did not epimerize.  We therefore concluded that at least one of 
the pro3 monomers within 27 was the site for the epimerization.  The most likely position for the 
epimerization was at C2 of the pyrrolidine ring, but exactly which pro3 monomer was 
epimerizing is not known. 
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The proximity of the two amino acid functional groups in 24 may account for its 
decreased stereochemical stability as compared to pro4 monomers.  In 24, the two amino acids 
are in a 1,2 relationship, whereas in the pro4 monomers the two amino acids are in a 1,3 
relationship.  The proximity of the electron withdrawing groups may lower the pKa of the C2 
hydrogen atom of the pyrrolidine ring allowing deprotonation at this position and subsequent 
epimerization..  
2.8 CONCLUSIONS 
Two pro3 class monomers, 13 and 24, with differing protecting group configurations 
were successfully synthesized.  In both 13 and 24 the amino acid functional groups are attached 
to adjacent carbon atoms.  We believe this placement of the amino acid groups has lead to poor 
performance of monomers 13 and 24 in bis-peptide synthesis. 
Neither 13 nor 24 were capable of producing quantitative amide bond formation with 
other bis-amino acids.  We believe the low yield of amide bond formation can be attributed to 
steric hindrance due to the proximity of the two amino acid functional groups.  Amide bond 
formation with sterically hindered amino acids is known to be difficult, as both the amine and 
acid can suffer reduced reactivity19,20.      
The incorporation of 24 into a diketopiperazine linked oligomer led to the discovery that 
the monomer was prone to epimerization in aqueous acidic solution.  Epimerization has not been 
seen in other diketopiperazine linked oligomers formed by our group, but no other monomer 
contains amino acids on adjacent carbon atoms.  We believe the proximity of the electron 
withdrawing amino acid groups causes the pro3 class of monomers to be prone to epimerization. 
The goals for the bis-amino acid linked oligomer project included the formation, in high 
yield, of stereochemically stable oligomers.  The pro3 class monomers formed did not satisfy 
either of these conditions.  We therefore chose not to proceed with further studies on the pro3 
monomer class.  
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2.9 GENERAL EXPERIMENTAL METHODS 
 THF was distilled from Na/benzophenone under N2.  CH2Cl2 was distilled from CaH2.  
All other reagents were used as received unless otherwise noted.  All reactions were carried out 
in flame-dried or oven-dried glassware under N2 atmosphere unless otherwise noted.  Column 
chromatography was performed either manually using ICN Silitech 32-63 D (60A) grade silica 
gel or using Redisep normal phase flash chromatography silica columns on Combiflash 
Companion Purification System from ISCO Inc.  NMR spectroscopy was performed on Bruker 
Avance 300 MHz, Bruker Avance DRX 500 MHz, or Bruker Avance DRX 600 MHz 
spectrometers.  Chemical shifts (δ) are reported relative to CDCl3, or DMSO-d6 residual solvents 
peaks, unless otherwise noted.  Optical rotation values were obtained on a Perkin-Elmer 241 
polarimeter at 25oC.  High resolution ESI-MS was performed on Hewlett-Packard Series 1050 
instrument with diode array detector, using a Varian Chrompack Microsorb 100 C18 column (5 
μm packing, 2.6 mm x250 mm).  HPLC-MS analysis was performed on a Hewlett-Packard 
Series 1100 instrument with a diode array detector, HP 1100 MS detector (ESI), using Waters 
Xterra MS C18 column (8 mm packing; 21.5 mm x 50 mm).  Analysis of 2D NMR data was 
performed using Sparky software. 
(2S,3S)-3-Oxo-1-(9-phenyl-9H-fluoren-9-yl)-pyrrolidine-2-carboxylic acid methyl ester (3). 
9-Phenylfluorenyl protected 3-Hydroxy-proline methyl ester (4) (1.84 g, 4.8 mmol) was 
dissolved in dry dichloromethane.  Previously dried 4-Methylmorpholine N-oxide (NMO) (0.94 
g, 8.0 mmol) and 2.6 g of activated 4A molecular sieves were added to the solution and then the 
flask was placed in an ice bath.  Tetrapropylammoniun perruthenate (TPAP) was immediately 
added in one portion and the flask was sealed under N2 atomsphere and stirred at 0oC for 10 
minutes and room temperature for 30 minutes more.  The reaction solution was filtered, and the 
filtrate was run through a silica pad with 2:1 ethyl acetate: hexanes.  The eluent was concentrated 
by rotary evaporation to an off-white solid.  Two sequential recrystallizations (recrystallization, 
dissolution in ethyl acetate followed by a second recrystallization) from neat ethyl acetate 
yielded 1.67 g (90.5%) of short, off-white crystalline solid. Mp = 122oC ORD  [α]D +73.4o 
(c.020, CHCl3); IR (neat):  3059, 2950, 1765, 1736, 1450, 1266, 1145, 741, 704 cm-1; 1H NMR 
(300 MHz, CDCl3): δ 7.79-7.14 (m, 13H, Ar), 3.65 (ddd, 1H, J = 18.2, 8.6, 3.7 Hz, -C5Hα), 3.34 
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(s, 1H, -C2H), 3.30 (s, 3H, - OCH3), 3.17 (ddd, 1H, J = 18.2, 9.1, 7.3 Hz, -C5Hβ), 2.65 (ddd, 1H, 
J = 17.7, 9.1, 8.6 Hz, -C4Hβ),  2.38 (ddd, 1H, J = 17.7, 7.3, 3.7 Hz, -C4Hα); 13C NMR (75 MHz, 
CDCl3): δ 208, 169, 146, 144, 141, 141, 139, 129, 128.7, 128.5, 127.6, 127.4 127.3, 127.2, 
127.1, 126, 120., 119, 76, 68, 51, 44, 37; HR MS (EI) calcd for C25H21NO3 (M+) 383.1521, 
found 383.1539. 
(2S,3S)-3-Hydroxy-2-Methoxycarbonyl pyrrolidine hydrochloride (6). 
(2S,3S)-3-Hydroxy-pyrrolidine-2-carboxylic acid (5) (2.04 g, 15.6 mmol) was dissolved 
in16 mL of methanol and HCl gas was bubbled through the methanol for five minutes after the 
last of the starting material became soluble.  The flask was sealed with a rubber stopper and let 
stir at room temperature for 2 hours.  The solvent was removed by rotary evaporation until a 
clear thick oil remained, which upon standing crystallized.  1H NMR (300 MHz, D2O):  δ 4.57 
(br s, 1H, -OH), 4.14 (br s, 1H, -C5H), 3.66 (s, 3H, -OCH3), 3.38 (t, 2H, -C5H2), 3.13 (s, 1H, -
C2H), 2.02 (m, 1H, -C4Hβ), 1.91 (m, 1H, -C4Hα);  13C NMR (75 MHz, D2O): 168, 73, 54, 44, 31. 
(2S,3S)-3-Hydroxy-1-(9-phenyl-9H-fluoren-9-yl)-pyrrolidine-2-carboxylic acid methyl ester 
(4). 
(2S,3S)-3-Hydroxy-2-methoxycarbonyl pyrrolidine hydrochloride (7) (2.00 g, 11.0 
mmol) was dissolved in 30 mL of dichloromethane followed by addition of chlorotrimethylsilane 
(2.8 mL, 22.0 mmol).  The flask was then cooled on an ice bath and diisopropylethylamine (6.7 
mL, 38.6 mmol) was added.  The flask was left at 0oC for five minutes then fitted with a reflux 
adapter and refluxed for 1.5 hours in an oil bath under N2.  The flask was cooled to 0oC and  
methanol (402 μL, 9.9 mmol) in 3 mL of dichloromethane was added with stirring under N2.  
The mixture was removed from the ice bath after five minutes and allowed to stir at room 
temperature for 1 hour.  9-Bromo-9-phenyl-9H-fluorene (5.25 g, 16.3 mmol), 
diisopropylethylamine (1.9 mL, 11.0 mmol), and lead (II) nitrate (3.33 g, 10.0 mmol) were 
added.  The flask was again flushed with N2, and the solution was stirred under N2.  The reaction 
mixture was allowed to stir for 18 hours and was filtered and concentrated by rotary evaporation.  
The resultant brown oil was diluted with 40 mL of methanol into which 4.2 g of citric acid were 
added and stirred at room temperature for 1 hour after which time the mixture was again filtered 
and concentrated.  The brown oil was brought up in 100 mL ethyl acetate and washed with 5% 
w/v citric acid in water (2 x 50 mL), saturated aqueous NaHCO3 (2 x 50 mL), then brine (1 x 50 
mL), dried with MgSO4 and concentrated by rotary evaporation.  The product was purified by 
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column chromatography with 1:3 ethyl acetate: hexanes over silica gel to yield 2.81 g (7.5 mmol, 
68.5%) of the light yellow solid title compound.  Analytical specimen was obtained by 
crystallization from ethyl acetate and hexanes.  Mp = 135.6oC   ORD [α]D +210.5o (c 0.022, 
CHCl3); IR (neat):  3443, 3057, 2946, 1729, 1450, 1207,1155, 741, 703 cm-1;  1H NMR 
(300MHz, CDCl3): δ 7.76-7.14 (m, 13H, Ar),  4.12 (ddd, 1H, J = 12.0, 4.8, 1.9 Hz, -C3H), 3.37 
(ddd, 1H, J = 9.2, 7.2, 2.4 Hz, -C5Hα),  3.35 (s, 3H, -OCH3), 3.18 (ddd, 1H, J =  9.8, 9.2, 5.5 Hz, 
-C5Hβ),  2.89 (d, 1H, J = 1.9 Hz, -C2H), 2.12 (dddd, 1H, J = 11.0, 9.8, 7.2, 4.8 Hz, -C4Hβ), 1.72 
(dddd, 1H, J = 12.0, 11.0, 5.5, 2.4 Hz, -C4Hα); 13C NMR (75 MHz, CDCl3): δ 174.6, 148.0, 
146.8, 145.8, 142.3, 141.6, 139.3, 128.6,128.2, 128.0, 127.7, 127.3, 127.1, 126.8, 126.3, 125.5, 
125.3, 120.0, 119.9, 69.7, 51.4, 46.7, 33.5; HR MS (EI) calcd for C25H23NO3 (M+) 385.1678, 
found 385.1681. 
9-Phenyl-9H-fluorene (8). 
Isolated as a byproduct of the Bucherer-Bergs reaction with PhF protected pyrrolidine 
nitrogen and the Corey-Link reaction.  1H NMR (300 MHz, CDCl3): δ 7.81, (d, 2H), 7.41-7.23 
(m, 9H), 7.10 (d, 2H), 5.06 (s, 1H). 
3-Hydroxy-1H-pyrrole-2-carboxylic acid methyl ester (9). 
Isolated as a byproduct of the Corey-Link and Bucherer-Bergs reactions.  1H NMR (300 
MHz, CDCl3): δ 8.13 (br s, 1H), 6.23 (br s, 1H), 5.89 (t, 1H), 3.89 (s, 3H). 
(2S,3R)-3-Hydroxy-1-(9-phenyl-9H-fluoren-9-yl)-3-trichloromethyl-pyrrolidine-2-
carboxylic acid methyl ester (11a). 
Compound 3 (1.63 g, 4.3 mmol) was dissolved in 90 mL tetrahydrofuran under an 
atmosphere of N2, and cooled to -78oC.  Chloroform (1 mL, 12.9 mmol) was added.  After five 
minutes 8.6 mL of 1 M lithium hexamethyldisilazane (LHMDS) was added.  The mixture was 
stirred at -78oC for 3 hours.  The solution was allowed to warm to -25oC before it was quenched 
with saturated aqueous ammonium chloride, removed from the bath, and allowed to reach room 
temperature.  The reaction was diluted with 100 mL water and extracted twice with 50 mL 
diethyl ether.  The organic layers were combined and washed with two portions of 50 mL water, 
50 mL of brine, and dried with MgSO4.  The solvent was removed under rotary evaporation to 
yield dark brown oil.  Purification of the material was possible with flash chromatography on 
silica gel eluted with 1:8 ethyl acetate hexanes.  Removal of solvent yielded 1.43 g (65.4%) of 
light yellow solid.  Analytical sample was recrystallized from ethyl acetate and hexanes. Mp = 
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126.7oC ORD [α]D +59.2o (c.016, CHCl3); IR (neat):3407, 3060, 2950, 2108, 1715, 1488, 1450, 
1209, 1177, 910, 791, 739, 703 cm-1; 1H NMR (300 MHz, CDCl3):  δ 7.80-7.09 (m, 13H, Ar) , 
5.29 (s, 1H, -OH), 3.76 (ddd, 1H, J = 12.5, 11.0, 6.2 Hz, -C5Hα), 3.73 (s, 1H, -C2H), 3.37 (ddd, 
1H, J = 12.5, 9.5, 7.1 Hz, -C5Hβ), 3.08 ( s, 3H, -OCH3), 2.44 (ddd, 1H, J = 12.2, 11.0, 9.5 Hz, -
C4Hβ),  2.07 (ddd, 1H, J = 12.2, 7.1, 6.2 Hz, -C4Hα); 13C NMR (CDCl3, 75 MHz): δ 175.6, 
147.3, 146.1, 143.1, 141.8, 139.6, 129.0,128.4, 128.1, 127.4, 127.0, 126.8, 125.60, 120.10,  
103.8, 91.7, 63.2, 52.3, 49.1, 36.3; HR MS (EI) calcd for C26H22Cl3NO3 (M+) 501.0665 found 
501.0655.  The stereochemistry of this molecule was assigned first by ROESy NMR 
spectroscopy and was subsequently confirmed by x-ray diffraction crystallography. 
(2S,3S)-3-Hydroxy-1-(9-phenyl-9H-fluoren-9-yl)-3-trichloromethyl-pyrrolidine-2-
carboxylic acid methyl ester (11b). 
Isolated as minor diastereomer of (11a).1H NMR (300 MHz, CDCl3): δ 7.97 (m,13H, 
Ar), 3.56 (ddd, 1H, J = 10.7, 9.4, 2.8 Hz, -C5Hα), 3.52 (s, 1H, -CαH), 3.45 (s, 1H, -OH), 3.29 
(ddd, 1H, J = 10.7, 8.8, 6.4 Hz, -C5Hβ), 3.27 (s, 3H, -OCH3), 2.44 (ddd, 1H, J = 12.0, 9.4, 8.8 
Hz, -C4Hβ), 2.36 (ddd, 1H, J = 12.0, 6.4, 2.8 Hz, -C4Hα); 13C NMR (75 MHz, CDCl3): δ 170.67, 
146.76, 145.56, 141.29, 140.79, 140.08, 129.04, 128.70, 128.60, 128.17, 127.70, 127.52, 127.02, 
126.46, 120.86, 120.22, 120.07, 75.08, 74.37, 68.97, 51.31, 44.92, 38.10. 
(2S,3S)-3-Azido-1-(9-phenyl-9H-fluoren-9-yl)-pyrrolidine-2,3-dicarcoxylic acid dimethyl 
ester (12). 
Trichlorocarbinol (11a) (1.68 g, 3.3 mmol) was dissolved in 30 mL of  dry methanol at 
room temperature.  To this solution was added sodium azide (1.12 g, 17.2 mmol), followed by 
1.8 mL of sodium methoxide 30% (w/v) in methanol.  The solution was allowed to stir at room 
temperature for 18 hours.  The reaction was diluted with 30 mL of 1 M HCl and extracted with 
diethyl ether (2 x 15mL). The organic layers were washed with water (2 x 15 mL), and then brine 
(1 x 15 mL), followed by drying with MgSO4.  The ether was removed with rotary evaporation. 
Flash chromatography over silica gel with 99:1 CHCl3:MeOH yielded 1.27 g (83.7%) of white 
solid title compound.  Crystalization was preformed using ethyl acetate and hexanes. Mp = 98oC 
(decomp.)  ORD [α]D +160.8o(c 0.0195, CHCl3); IR (neat):  2108, 1744, 1450, 1435, 1264, 
1197, 1160 cm-1; 1H NMR (300 MHz, CDCl3):δ 7.75-7.07 (m, 13H, Ar), 3.63 (s, 3H, -OCH3), 
3.53 (dd, J = 11.6, 7.5 Hz, 1H, -C5Hα), 3.29 (s, 3H, -OCH3), 3.26 (ddd, 1H, J = 11.6, 10.5, 5.7 
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Hz, -C5Hβ), 3.22 (s, 1H, -CαH), 2.62 (ddd, 1H, J = 12.9, 10.5, 7.5 Hz, -C4Hβ), 1.82 (dd, 1H, J = 
12.9, 5.7 Hz, -C4Hα); 13C NMR (75 MHz, CDCl3):  δ 172.1, 169.0, 147.8, 145.3, 141.8, 141.5, 
139.5, 129.1, 128.5, 128.4, 127.9, 127.6, 127.2, 126.7, 120.3, 120.1, 75.6, 74.4, 67.3, 52.9, 51.8, 
46.6, 33.2; HR MS (EI) calcd for C27H24N4O4 (M+) 468.1798, found 468.1794.  
(2S,3S)-3-Azido-1-(9-phenyl-9H-fluoren-9-yl)-pyrrolidine-2,3-dicarboxylic acid 2-methyl 
ester (13). 
The trichlorocarbinol (11a) (811.5 mg, 1.6 mmol) was dissolved in dioxane (8 mL) and 
diluted with 5 mL of water.  Sodium hydroxide (303.4 mg, 7.6 mmol) was added to the solution 
followed quickly by sodium azide (234.2 mg, 3.6 mmol).  The reaction was stirred at room 
temperature for 1 hour.  The reaction was diluted with 10 mL of 1 M HCl and 10 mL of diethyl 
ether and the aqueous and organic layer were separated.  The aqueous layer was extracted 2 
times with ether (10 mL each).  The ether was washed twice with saturated aqueous sodium 
bicarbonate (10 mL each), then washed once with 10 mL of brine.  The organic layer was dried 
with MgSO4 and concentrated under rotary evaporation to give the title compound as clear oil 
(692.8 mg, 95.2% yield).  ORD [α]D +124.5o (c = 0.0157, CHCl3); IR (neat): 3059, 2951, 2109, 
1742, 1450, 1250, 1162, 740, 703 cm-1; 1H NMR (300 MHz, CDCl3):  7.94-7.11 (m, 13H, Ar), 
3.50 (ddd, J = 13.3, 8.0, 1.2 Hz, 1H, -CδHα), 3.27 (ddd, J = 13.3, 10.2, 5.6 Hz, 1H, -CδHβ), 3.23 
(s, 3H, -OCH3), 3.22 (s, 1H, -CαH), 2.57 ( ddd, J = 12.9, 10.2, 8.0 Hz, 1H, -CγHβ), 1.83 (ddd, J = 
12.9, 5.6, 1.2 Hz, 1H, -CγHα); 13C NMR (75 MHz, CDCl3): 173.4, 172.1, 147.4, 144.9, 141.5, 
141.3, 139.2, 129.0, 128.4, 128.3, 127.7, 127.4, 127.1, 126.5, 126.5, 120.1, 119.9, 75.5, 73.9, 
66.8, 51.8, 46.6, 32.8; HR MS (EI) calcd for C25H21N4O2  
(2S,3S)-3-Azido-pyrrolidine-2,3-dicarboxylic acid dimethyl ester (14). 
Phenyl-fluorenyl protected azido dimethyl ester (12) (76.1 mg, 0.16 mmol) was dissolved 
in dichloromethane, and methanol (20 μL, 0.48 mmol) was added.  To this solution was added 
50 μL of trifluoroacetic acid with stirring for 2 hours.  The reaction mixture was concentrated by 
rotary evaporation to yellow oil.  The oil was introduced to a 5 mL silica pad and run with 
chloroform to remove the aromatic residue.  Next, the pad was washed with 1 % (v/v) 
triethylamine in chloroform to neutralize the pyrrolidine salt and move it off the silica.  Rotary 
evaporation of those fractions containing the pyrrolidine provided the title compound as yellow 
oil (34.8 mg, 95.5% yield).  ORD [α]D +5.17 (c 0.0358, CHCl3); IR (thin film):  3323, 3155, 
2955, 2115, 1749, 1450, 1437, 724 cm-1; 1H NMR (300 MHz, CDCl3): δ 3.86 (s, 1H, -C2H), 3.78 
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(s, 3H, -OCH3), 3.73 (s, 3H, -OCH3), 3.31 (ddd, 1H, J = 11.4, 8.0, 3.5 Hz,-C5Hα), 3.06 (ddd, 1H, 
J = 11.4, 8.4, 7.1 Hz, -C5Hβ), 2.32 (ddd, 1H, J = 13.3, 8.4, 7.1 Hz, -C4Hβ), 2.06 (ddd, 1H, J = 
13.3, 7.1, 3.5 Hz, -C5Hα); 13C NMR (75 MHz, CDCl3): 170.8, 170.3, 74.8, 70.8, 53.0, 52.5, 45.9, 
38.1. 
(2S,3S,2’S,3’S)-3’-Azido-1[3-azdio-2methoxycarbonyl-1-(9-phenyl-9H-fluoren-9-yl)-
pyrrolidine-3-carbonyl]-pyrrolidine-2’,3’-dicarboxylic acid dimethyl ester (15). 
HATU coupling method in 20% dimethylformamide/dichloromethane: The phenyl-
fluorenyl protected 3-carboxylic acid pyrrolidine (13) (53.8 mg, 0.12 mmol) was dissolved in 
dichloromethane (960 μL) and dimethylformamide (240 μL), and HATU (51.4 mg, 0.14 mmol) 
was added to the mixture.  Diisopropylethylamine amine was added and the solution was stirred 
for 2 minutes after which the 1H-pyrrolidine (14) (27.0 mg, 0.12 mmol) was added.  The reaction 
was stirred under N2 for 24 hours and was diluted with 1 mL 1 M HCl.  The reaction mixture 
was transferred to a separation funnel and extracted with dichloromethane (3 x 5 mL).  The 
organic layer was dried with sodium sulfate and concentrated.  Flash chromatography with 1:3 
ethyl acetate: hexanes gave a mixture of the product and the starting acid.  This mixture was 
separated using a 5 mL silica pad eluted with neat chloroform to provide pure title compound as 
clear oil (27.6 mg, 34.6% yield).  ORD +32.2o (c 0.038, CHCl3); IR (neat):  2953, 2107, 1749, 
1650, 1450, 1435, 1264, 1174, 735 cm-1; 1H NMR (300 MHz, CDCl3)(rotational isomers 
unresolved at 360 K in d6-DMSO): δ 7.72-7.22 (m, 13 H), 4.08 (m, 1H), 3.84 (m, 1H), 3.80 (s, 
3H), 3.68-3.65 (m, 3H), 3.55-3.50 (m, 2H), 3.32-3.30 (m, 1H), 3.29-3.28 (m, 3H), 3.04 (m, 1H), 
2.57 (m, 1H), 2.22 (m, 2H), 1.96 (m, 1H); HR MS (EI) calcd for C34H32N5O7 ([M-N3]+) 
622.2296 found 622.2278.   
HOBt/DCC coupling method:  The 1H-pyrrolidine (13) (20.2 mg, 0.09 mmol) was 
dissolved in 2 mL of 1:4 tetrahydrofuran: dichloromethane and the 3-carboxylic acid pyrrolidine 
(14) (51.7 mg, 0.11 mmol) was added, followed by addition of dicyclohexyl carbodiimide (26.9 
mg, 0.13 mmol) and HOBt (1-hydroxybenzotriaxzole) (16.5 mg, 0.12 mmol).  The reaction was 
stirred at 0oC for three hours and allowed to warm to room temperature, with stirring, for an 
additional 18 hours.  Concentration under rotary evaporation of the reaction mixture resulted in a 
yellow residue that was brought up in 10 mL ethyl acetate, washed with 1 M HCl (2 x 10 mL), 
saturated aqueous sodium bicarbonate (2 x 10 mL), and brine (1 x 10 mL).  The organic layer 
was dried with MgSO4 and concentrated.  The residue was purified by flash chromatography (1:6 
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ethyl acetate hexanes), yielding what appeared, by 1H NMR to be the OBt ester (16) of the acid 
starting material along with the acid starting material.  1H NMR (300 MHz, CDCl3): δ 7.83-7.16 
(m, 17H, Ar), 3.54 (ddd, 1H, J = 10.0, 9.8, 2.1 Hz, -C5Hα), 3.34 (s, 3H, -OCH3), 3.15 (ddd, 1H, J 
= 10.0, 7.5, 4.0 Hz, -C5Hβ), 3.12 (s, 1H, -C2H), 2.42 (ddd, 1H, J = 12.1, 9.8, 7.5 Hz, -C4Hβ), 2.03 
(ddd, 1H, J = 12.1, 4.0, 2.1 Hz, -C4Hα). 
PyBroP coupling method:  The free amine (14) (51.3 mg, 0.22 mmol) was dissolved in 
dichloromethane.  The 3-carboxylic acid (13) (125.9 mg, 0.27 mmol) was added to the solution 
along with PyBroP (bromotripyrrolidinophosphonium hexafluorophosphate) (154.8 mg, 0.33 
mmol) and diisopropylethylamine (77 μL, 0.44 mmol).  The reaction was stirred under N2 for 24 
hours, after which the solvent was removed and the residue was taken up in ethyl acetate (10 
mL).  The organic layer was washed three times with 5% KHSO4 (10 ml), then 10 mL brine, 
three 10 ml portions of saturated aqueous sodium bicarbonate, and finally with one portion of 10 
mL brine.  The organic layer was dried with Na2SO4, and concentrated under rotary evaporation.  
Flash chromatography with 1:3 hexanes provided the dimeric product in 27.1% yield (38.8 mg). 
HATU coupling method in neat dimethylformamide: The 3-carboxylic acid (13) (91.7 
mg, 0.20 mmol)  was dissolved in dimethylformamide (1 mL), and HATU (83.0 mg, 0.22 mmol) 
was added along with diisopropylethylamine amine (45 μL, 0.26mmol).  The mixture was stirred 
for two minutes after which the free amine (14) (30.3 mg, 0.13 mmol) was introduced.  The 
reaction was stirred under N2 for 24 hours, after which it was diluted with 30 ml ethyl acetate.  
The solution was washed with 1 M HCl (2 x 10mL), water (1 x 10 mL), saturated aqueous 
sodium bicarbonate (2 x 10 mL), and 10 mL of brine, and dried with MgSO4.  Rotary 
evaporation yielded yellow oil that was introduced to a silica gel column for flash 
chromatography with 1:3 ethyl acetate hexanes to yield the dimer in 8.6% yield (11.4 mg). 
(2S,3S)-allyl 3-Hydroxypyrrolidine-2-carboxylate Hydrochloride (17) 
(2S,3S)-3-hydroxyproline (5.14 g, 38.1 mmol) was suspended in allyl alcohol (50 mL) 
and HCl gas was bubbled through until a homogenous solution resulted.  The solution was sealed 
and stirred for 2 hours.  The solution was evaporated by rotary evaporation and allowed to sit 
until solidification occurred to a light brown crystalline solid. Yield 7.89g, 100%.  1H NMR (300 
MHz, DMSO) δ 9.81 (br s, 1H),  5.94 (m, 1H), 5.37 (ddd, J = 17.4, 3.3, 1.8 Hz, 1H),  5.26 (ddd, 
J = 10.5, 3.0, 1.5 Hz, 1H) 4.69 (m, 2H), 4.36 (m, 1H) 4.16 (d,  J = 3.0 Hz, 1H) 3.33 (m, 2H), 1.94 
(m, 2H). 
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(2S,3S)-allyl 3-hydroxy-1-(9-phenyl-9H-fluoren-9-yl)pyrrolidine-2-carboxylate (18) 
Compound 17 (8.78 g, 42.4 mmol) was suspended in 100 ml DCM.  
Trimethylsilylchloride (12.1 mL, 95.4 mmol) was added followed by DIPEA (24.2 mL, 148.4 
mmol).  This solution was refluxed under N2 for 1 hour then cooled to 0oC. 1.5 ml of methanol in 
10.6 ml DCM was added and the solution was stirred for 1 hour at 0oC.  Phenylfluorenyl-
bromide (20.56g, 69.0 mmol), lead II nitrate (13.59g,  41.0 mmol), and DIPEA (6.9 mL, 42.4 
mmol) were added and the solution was stirred under N2 overnight.  The solution was evaporated 
and the residue was brought up in a solution of 10% w/v citric acid in methanol (50 mL) and 
stirred for 1 hour.  The methanol was evaporated and the residue was brought up in ethyl acetate 
(300 mL).  This solution was washed with water (100 mL) three times and brine once dried and 
evaporated.  A column of 1:3 EtOAc:hexanes was run.  The resulting product was evaporated 
and recrystallized from EtOAc and hexanes to yield off-white crystals (13.14g, 75.3%). Mp = 
152.5oC ORD [α]D +184.6o(c 0.0412, CHCl3); IR (neat):  3447, 3058, 3019, 2940, 2873, 1733, 
1450, 1154, 986, 742, 703 cm-1; 1H NMR (300 MHz,  CDCl3) δ 7.83-7.11 (m, Ar, 13H), 5.71 ( 
ddd, J = 6.0, 5.6, 5.3 Hz, 1H), 5.19 (dd, J = 5.3, 1.2 Hz, 1H), 5.14 (d, J = 1.2 Hz, 1H), 4.29 (dd, J 
=  13.2, 6.0 Hz, 1H), 4.14 (dd, J = 13.2, 5.6 Hz, 1H), 3.37 (ddd, J = 15.9, 7.7, 2.4 Hz, 1H), 3.19 
(ddd, J = 15.9, 10.1, 5.8 Hz, 1H), 2.93 (dd, J = 3.6, 2.1 Hz, 1H) 2.11 (m, J = 15.5, 5.8, 2.4, 2.1, 
1H), 2.06 (d, J = 3.6, 1H) 1.73 (ddd, J = 15.5, 10.1, 7.7 Hz, 1H); 13C NMR (125 Mz, CDCl3) 
173.7, 148.0, 145.9, 142.3, 141.5, 139.3, 131.9, 128.5, 128.3, 127.7, 127.4, 127.2, 127.1, 126.8, 
126.3, 120.0, 119.7, 118.1, 76.0, 75.9, 69.7, 65.0, 46.7, 33.4; HR MS (EI) calcd for C27H25N1O3 
(M+) 411.1834, found 411.1823. 
(S)-allyl 3-oxo-1-(9-phenyl-9H-fluoren-9-yl)pyrrolidine-2-carboxylate (19) 
Into 30 ml of DCM, 1.2 ml (13.5 mmol) of oxalyl chloride was added under N2 and 
stirred.  The solution was cooled to -78oC  and 1.9 mL (26.8 mmol) of DMSO was added and 
stirred for 2 min.  5.04 g (12.2 mmol) of 18 was dissolved in 24 mL of1:1 DCM:DMSO and 
added to the above solution.  After 5 minutes 8.1 mL (61.0 mmol) of TEA was added.  The 
reaction was allowed to warm to room temperature over two hours when 50 ml of H2O was 
added.  Extraction with DCM x2 of the aqueous layer and combination of the organic layers 
followed.  The organic layers were washed with 1M HCl x2, sat aq NaHCO3 x2, then brine.  The 
solution was dried with MgSO4 and concentrated.  A silica column eluted with 1:6 
EtOAc:hexanes yielded the title compound as a yellow oil (3.9976 g, 80.0% yield). ORD [α]D 
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+43.0o(c 0.0217, CHCl3); IR (neat):  3439, 3060, 3021, 2945, 2871, 1765, 1736, 1450, 1143, 
741, 703 cm-1; 1H NMR (300 MHz,  CDCl3) δ 8.02-7.25 (m, Ar, 13H), 5.69 ( ddd, J = 11.25, 5.7, 
5.5 Hz, 1H), 5.20 (ddd, J = 11.25, 1.5, 1.4 Hz, 1H), 5.16 (ddd, J = 2.8, 2.7, 1.4 Hz, 1H), 4.20 (m, 
J =  13.3, 5.7, 2.7, 1.4 Hz, 1H), 4.08 (dddd, J = 13.3, 5.5, 2.8, 1.5 Hz, 1H), 3.67 (ddd, J = 18.3, 
8.5, 3.9 Hz, 1H), 3.38 (s, 1H) 3.17 (ddd, J = 18.3, 8.9, 7.3 Hz, 1H), 2.64 (ddd, J = 17.4, 8.9, 8.5 
Hz, 1H) 2.40 (ddd, J = 17.4, 7.3, 3.9 Hz, 1H); 13C NMR (75 Mz, CDCl3); 208.6, 168.5, 146.3 
144.0, 141.4, 140.9, 139.7, 131.4, 128.9, 128.6, 128.4, 128.1, 127.5, 127.5, 127.2, 127.1, 126.4, 
120.2, 119.8, 117.9, 76.5, 76.0, 68.4, 65.4, 44.3, 37.4; HR MS (EI) calcd for C27H23N1O3 (M+) 
409.1678, found 409.1671. 
(2S,3R)-allyl 3-(trichloromethyl)-3-hydroxy-1-(9-phenyl-9H-fluoren-9-yl)pyrrolidine-2-
carboxylate (20) 
In 150 mL of THF, 3.9976g (9.8 mmol) of 19 was dissolved and the solution cooled to -
78oC.  Chloroform (7.8 mL, 98 mmol) was added followed by 10.8 ml (10.8 mmol) of 1 M 
LHMDS in THF.  The reaction was stirred under N2 for 4 hours at -78oC.  The reaction was 
allowed to warm to RT and 50 mL saturated aqueous ammonium chloride was added along with 
50mL of ether.  The organic layer was washed x3 with H2O then brine x1, dried and 
concentrated.  Silica flash column eluted with 1:2 EtOAc:hexanes and recyrstallization from 
chloroform/hexanes yielded the title product as white crystals (3.3021 g, 61.2% yield).  Mp = 
112.1oC ORD [α]D +86.3o(c 0.0179, CHCl3); IR (neat):  3409, 3059,3020, 2888, 1713, 1450, 
1191, 791, 741, 726, 702  cm-1; 1H NMR (300 MHz,  CDCl3) δ 7.89-7.25 (m, Ar, 13H), 5.53 ( m, 
1H), 5.13 (m, 2H), 5.08 (dd, J = 9.0, 1.4 Hz, 1H), 4.15 (ddd, J =  12.9, 6.9, 1.4 Hz, 1H), 3.79 (s, 
1H), 3.71 (m, 2H), 3.36 (ddd, J = 10.8, 9.0, 1.4 1H), 2.50 (ddd, J = 20.1, 9.0, 1.4 Hz, 1H) 2.11 
(ddd, J = 20.1, 10.8, 1.4 Hz, 1H); 13C NMR (75 Mz, CDCl3); 174.5, 147.1, 146.1, 143.0, 141.5, 
139.7, 130.8, 128.9, 128.5, 128.4, 128.0, 127.4, 127.4, 126.9, 126.8, 125.6, 120.1, 120.0, 119.0, 
103.9, 91.7, 77.3, 77.2, 66.4,63.7,48.9,36.4; HR MS (EI) calcd for C28H24NO3Cl3 (M+) 
527.0822, found 527.0816. 
(2S,3S)-2-allyl 3-methyl 3-azido-1-(9-phenyl-9H-fluoren-9-yl)pyrrolidine-2,3-dicarboxylate 
(21) 
In dry methanol (50 mL), 20 (2.97 g, 5.6mmol) was dissolved and sodium azide (1.81 g, 
27.8 mmol), 18-crown-6 (88.6 mg, 6.0 mole%) and DBU (4.2 ml, 28 mmol) were added.   The 
flask was sealed and stirred under N2 overnight.  Saturated ammonium chloride solution (50 ml) 
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was added to the reaction along with 50 ml of ether.  The ether layer was washed with 1M HCl 
x2 then brine x1.  The organic layer was dried and concentrated.  The product was recovered as 
white crystals from crystallization with chloroform/hexanes (2.22g, 80.3 % yield). Mp = 92.5oC 
(decomp.)  ORD [α]D +119.4o(c 0.0388, CHCl3); IR (neat):  3409, 3059,3020, 2888, 2109, 1741, 
1646, 1450, 1263, 1157, 742, 726, 704  cm-1; 1H NMR (300 MHz,  CDCl3) δ 8.0-7.13 (m, Ar, 
13H), 5.69 ( m, 1H), 5.20 (m, 1H), 5.15 (m, 1H), 4.21 (dddd, J =  22.5, 10.5, 1.4, 1.2 Hz, 1H), 
4.17 (dddd, J = 22.5,  10.5, 1.4, 1.2, 1H), 3.62 (s, 3H), 3.55 (ddd, J = 10.8, 9.5, 1.4 1H), 3.31 
(ddd, 10.8, 7.8, 6.0) 3.25 (s, 1H) 2.64 (ddd, J = 12.9, 9.5, 7.8 Hz, 1H) 1.84 (ddd, J = 12.9, 6.0,1.4 
Hz, 1H); 13C NMR (75 Mz, CDCl3) 171.1, 168.9, 147.7, 145.6, 141.9, 141.4, 139.6, 131.9, 
129.1, 128.5, 128.4, 127.8, 127.6, 127.5, 127.3, 126.8, 126.7, 124.8, 120.2, 118.4, 75.7, 74.4, 
67.5, 65.7, 52.7, 46.6, 33.0; HR MS (EI) calcd for C29H26N4O4 (M+) 494.1954, found 494.1935. 
(9H-fluoren-9-yl)methyl (2S,3S)-2-((allyloxy)carbonyl)-3-(methoxycarbonyl)-1-(9-phenyl-
9H-fluoren-9-yl)pyrrolidin-3-ylcarbamate (22) 
In 40 ml of 1:1 acetic acid:THF were dissolved 3.30 g of 21.  Added to the flask was 4.42 
g of Zn dust.  The reaction was allowed to stir vigorously for 1 hour at which time the Zn dust 
was filtered off and the filtrate was diluted with 100 ml of EtOAc.  The filtrate solution was 
washed with saturated aqueous NaHCO3 x3, H2O x2, then brine x1, dried and concentrated.  No 
further purification was done on the clear oil/white foam product.  The product (2.44 g, 5.2 
mmol) was dissolved in 30 ml of DCM and 1.73 g (6.7 mmol) of Fmoc-Cl was added along with 
1.0 mL (6.2 mmol) DIPEA.   The reaction was stirred under N2 for 2 hours at which time the 
reaction was complete and the solution was concentrated.  The residue was brought up in 1:3 
EtOAc:hexanes and a flash column was run over silica eluting with the same solution.  This 
yielded 3.47 g (96.7 %) of the title product as a white foamy solid. ORD [α]D +237.5o(c 0.0336, 
CHCl3); IR (neat):  3417, 3019, 2950, 2878, 1751, 1727, 1497, 1449, 1295, 1239, 1158, 741, 
704, 637  cm-1; 1H NMR (300 MHz,  CDCl3) δ 7.95-7.15 (m, 22H) 5.75 (m, 1H), 5.32-5.19 (m, 
2H) 4.39 (dd, J = 17.1, 9.6 Hz, 1H), 4.26 (dd, J = 7.2, 6.6 Hz, 1H) 4.22-4.05 (m, 3H), 3.72 (s, 
1H), 3.53 (s, 3H), 3.48 (ddd, J = 10.5, 5.1, 1.2 Hz, 1H), 3.27 (ddd, J = 10.5, 8.1, 1.5 Hz, 1H) 2.56 
(ddd, J = 11.7, 8.1, 1.2 Hz, 1H), 2.26 (ddd, J = 11.7, 5.1, 1.5 Hz, 1H); 13C NMR (75 Mz, 
CDCl3);170.8, 170.2, 154.8, 146.5, 143.8, 143.6, 142.4, 140.7, 139.9, 129.5, 132.4, 128.2, 127.7, 
127.3, 127.1, 126.9, 126.6, 125.8, 125.3, 125.1, 120.1, 117.8, 74.5, 67.0, 66.3, 65.6, 64.4, 52.1, 
46.5, 44.9, 42.8, 33.3; HR MS (EI) calcd for C44H38N2O6 (M+) 690.2730, found 690.2719. 
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(9H-fluoren-9-yl)methyl (2S,3S)-2-((allyloxy)carbonyl)-1-(tert-butoxycarbonyl)-3-
(methoxycarbonyl)pyrrolidin-3-ylcarbamate (23) 
Compound 22 (3.37 g, 4.9 mmol) was dissolved in 40 ml DCM, 10 ml TFA and 600 μl of 
methanol were added.  The reaction was allowed to stir for 1 hour.  Upon completion the 
solution was washed with water x2.  The aqueous layers were combined and made basic with 
NaHCO3.   The basic aqueous solution was extracted x2 with DCM.  All organic layers were 
combined and washed with saturated NaHCO3 x2 and brine x1.  The organic layer was dried and 
concentrated.  The resulting reddish oil was taken up in 50 ml of DCM into which were added 
880 ml (5.4 mmol) of DIPEA and 1.60 g (5.4 mmol) of Boc2O.  The reaction was stirred under 
N2 for two hours.  Upon completion the solution was concentrated and a flash column of 1:3 
EtOAc:hexanes was performed to purify material.  Yield of product was 2.38 g (88.1%) of clear 
oil.  ORD [α]D +49.7o(c 0.0201, CHCl3); IR (neat):  3318, 3020, 2997, 2897, 1755, 1681, 1525, 
1410, 1247, 1182, 758, 666 cm-1; 1H NMR (300 MHz,  DMSO, 350K) δ 8.03 (s, 1H), 7.85 (d, J 
= 7.2, 2H), 7.68 (d, J = 7.2, 2H), 7.40 (m, 4H), 5.87 (m, 1H), 5.38 (d, J = 12.4 Hz, 1H), 5.29 (d, J 
= 10.8 Hz, 1H), 4.58-4.40 (br m, 5H), 4.22 (t, J = 7.2, 1H), 3.60-3.54 (m, 4H), 3.34 (br s, 1H), 
2.50-2.44 (br m, 2H), 1.36 (br s, 9H) ; 13C NMR (75 Mz, DMSO 350 K) 168.8, 168.4, 154.9, 
152.3, 143.4, 143.3, 140.5, 131.5, 127.2, 126.6, 124.7, 119.6, 118.2, 79.1, 78.7, 67.4, 66.5, 65.4, 
65.2, 52.0, 46.5, 43.4, 27.6; HR MS (ES) calcd for C30H34N2O8Na (M+) 573.2237, found 
573.2225. 
(9H-fluoren-9-yl)methyl (2S,3S)-2-(carbomethoxy)-1-(tert-butoxycarbonyl)-3-
(methoxycarbonyl)pyrrolidin-3-ylcarbamate (24) 
Compound 23 (2.34 g, 3.8 mmol) was dissolved in 40 mL of THF, Pd(PPh3)4 (277.7 mg, 
0.24 mmol) and morpholine (365 μL, 4.2 mmol) were added.  The reaction was sealed and 
stirred under N2 for 1.5 hours.  After completion the reaction solution was washed with 1M HCl 
three times and once with brine.  The organic layer was dried, concentrated and purifed by 
automated flash chromatography (gradient 0-10% MeOH in CHCl3).  Product isolated in 93.4 % 
yield as off-white foam. %).  ORD [α]D +43.8o(c 0.0459, CHCl3); IR (neat):  3307, 3011, 2978, 
1755, 1710, 1683, 1527, 1450, 1412, 1251, 1162, 758, 666 cm-1; 1H NMR (300 MHz,  DMSO, 
345K rotational isomers not fully resolved) δ 8.01 (s, 1H), 7.84 (d, J = 7.2, 2H), 7.68 (d, J = 7.2, 
2H), 7.40 (m, 4H), 4.40 (br m, 3H), 4.22 (t, J = 7.2, 1H), 3.62-3.51 (m, 4H), 3.32 (br s, 1H), 2.50 
(br m, 1H), 2.30 (br m, 1H), 1.38 (br s, 9H) ; 13C NMR (75 Mz, DMSO 350 K) 169.9, 169.0, 
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155.0, 152.7, 143.5, 143.4, 140.5, 127.2, 126.6, 124.7, 124.7, 119.6, 78.8, 67.5, 65.7, 65.2, 51.9, 
46.6, 43.4, 30.4 %).  HR MS (ES) calcd for C30H34N2O8Na (M+) 573.2237, found 573.2225. 
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3.0   SYNTHESIS OF PIP4(2S4R)AND PIP4(2S4S) MONOMERS 
3.1 OVERVIEW OF PIP MONOMER CLASS 
  Our ability to design molecules which place functional groups in close proximity to each 
other is dependent upon the formation of curved oligomeric sequences.  The formation of a 
greater number of curved oligomeric sequences requires the development of new bis-amino acid 
monomers.  We therefore have continued the expansion of our bis-amino acid monomer library.  
To further expand our library we have taken a side product formed in the synthesis of  the 
pip5(2S5S) bis-amino acid monomer5 and created a new class of monomer, the pip4 class 
(Figure 15). 
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Figure 15. Currently Developed Pip Class Monomers 
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 Gupta, Das and Schafmeister reported the synthesis of the pip5(2S5S) monomer5, 1 
(Figure 15).  During the synthesis of this monomer, a ring expansion homologation reaction was 
performed which produced the regio-isomeric ketones 8 and 9 (Scheme 10).  Ketone 8 was used 
in the synthesis of 1, while ketone 9 was not used and was set aside for later development into 
pip4 monomers.  In this chapter, I describe the transformation of ketone 9 into the pip4(2S4R) 
monomer 2 and pip4(2S4S) monomer 3 (Figure 15). 
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a.) ethyldiazoacetate, BF3.etherate b.) Krapcho decarboxylation  
Scheme 10. Formation of 4-oxo and 5-oxo-Pipecolic Acid Derivatives Using Ethyldiazoacetate 
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3.2 SYNTHESIS OF 4-OXO AND 5-OXO-PIPECOLIC ACID DERIVATIVES 
Scheme 10 shows the homologation reaction of ketone 5 as developed by Pellicciari21 
and coworkers and used by Gupta and coworkers5,21  to form pipecolic acid derived ketones 8 
and 9.  This reaction yielded a 5:4 mixture of 8 and 9 respectively in a variable yield (35-50%) 
over two steps.  The method utilized the addition of ethyl diazoacetate to ketone 5, with ring 
homologation resulting upon loss of N2 to form intermediates 6 and 7.  β-Keto-esters 6 and 7 
were subjected to Krapcho decarboxylation conditions to yield ketones 8 and 9. 
I set out to develop a higher yielding homologation reaction.  This reaction utilized 
borontrifluoride catalyzed addition of trimethylsilyldiazomethane into ketone 5 (Scheme 11)22, 
followed by subsequent ring expansion with loss of N2 to form intermediates 10 and 11.  
Removal of the trimethylsilyl group with K2CO3 in methanol resulted in the formation of 8 and 9  
in a 4:5 ratio and overall yield of 36%.  The isomeric ratio was determined by 1H NMR 
spectroscopy of the crude reaction mixture. 
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a.) TMS-CH=N2, BF3.etherate, -78oC to RT b.) K2CO3, methanol. 
Scheme 11. Formation of 4-oxo and 5-oxo-Pipecolic Acid Derivatives Using Trimethylsilyldiazoemthane 
 
As the yields of the two homologation methods were comparable, our choice to use a 
particular homologation method would be driven by the monomer class to be synthesized.   The 
pip5 monomer utilized ketone 8 in its formation and would benefit from the use of the conditions 
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developed by Pellicciari, which produced ketone 8 in greater proportion.  Our development of 
the pip4 monomer was based on the use of ketone 9.  Ketone 9 was the major product of the  
trimethylsilyldiazomethane homologation reaction and would indicate the further use of this 
method in the development of the pip4 monomer class.  Both routes have similar yield and 
further work needs to be done to improve one or both of these routes. 
3.3 STEREOCHEMISTRY OF THE BUCHERER BERGS REACTION PRODUCTS 
Samples of ketone 9 were produced through both homologation methods and were 
combined prior to use in a Bucherer-Bergs reaction11,12.  The Bucherer-Bergs reaction was used 
to convert the ketone at C4 of 9 into diastereomeric hydantoins 12 and 13. These compounds 
were utilized as precursors to the formation of the α-amino acid at C4 of the pip4 monomers 2 
and 3. 
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Scheme 12. Products of the Bucherer-Bergs Reaction 
 
The Bucherer-Bergs reaction formed a mixture of spiro-hydantoin diastereomers 12 and 
13 in a 7:2 ratio, as measured by 1H NMR spectroscopy, in 65% overall yield (Scheme 12).  The 
separation of 12 and 13 was performed by silica gel column chromatography (chromatography 
was performed on an ISCO chromatography system with a gradient: 1:8 to 1:2 ethyl acetate in 
hexanes). 
We attempted to determine the stereochemistry of 12 using a NOESY NMR experiment, 
but the NOESY spectrum of 12 was ambiguous in terms of the assignment of the C4 
stereochemistry.  I rationalized that the Cbz group would be forcing the adjacent t-butyl ester 
into a pseudo-axial orientation, and forcing the six-membered ring to adopt the chair 
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conformation shown in Figure 16.  I further rationalized that if I removed the Cbz group, the six 
membered ring could flip into the other chair conformation giving rise to a new set of NOESY 
correlations that might be easier to interpret.  The Cbz group was removed from 12 by 
hydrogenolysis to produce 14 (Figure 16).  A NOESY spectrum of 14 was obtained.  In the 
spectrum a correlation was observed between the C2 hydrogen atom and one of the geminal C6 
hydrogen atoms suggesting a 1,3 diaxial arrangement for these hydrogens (Figure 16).  One 
geminal hydrogen atom on C3 of the piperidine ring and one geminal hydrogen atom on C5 also 
displayed a correlation in the NOESY spectrum, but no correlations were observed between 
either of the C3 hydrogen atoms and either C6 hydrogen atom.  Nor was a correlation observed 
between the C2 hydrogen atom and either C5 hydrogen atom.  This arrangement of NOESY 
correlations is consistent with the chair conformation of 14 shown in Figure 16, where the axial 
C3 hydrogen atom and the axial C5 hydrogen atom are on the opposite face of the piperidine ring 
from the C2 hydrogen atom.  The stereochemistry at C4 of the pyrrolidine ring was assigned by 
the presence of a NOESY correlation between the hydantoin amide proton with both of the C3 
and C5 axial protons as shown in Figure 16.  The stereochemistry of the C4 center on 13 could 
not confirmed by NOE spectroscopy due to resonance overlap, but was inferred to be opposite 
the stereochemistry of the C4 center on 12. 
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Correlations seen in the NOESY spectrum of 14 that helped to determine the stereochemistry at the C4 center are 
shown as red curves. 
Figure 16. NOESY Interactions seen in Major Hydantoin Diastereomer 
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Figure 17. Mechanism of the Bucherer-Bergs Reaction 
3.4 DIASTEREOSELECTIVITY OF THE BUCHERER-BERGS REACTION 
In a study of the Bucherer-Bergs reaction mechanism performed by Edward and 
Jitrangsri23 on 4-tert-butyl cyclohexanone, it was found that the rate limiting step of the 
hydantoin formation involved intermediates similar to 17 and 18 (Figure 17).  The rate limiting 
step was determined to be the attack of the carboxylate oxygen into the nitrile carbon attached to 
C4 of these two intermediates.  In 18, this attack forced the nitrile nitrogen atom to approach the 
axial C2 ester and axial C6 hydrogen atom in the transition state.  In 17, the attack of the 
carboxylate does not produce as great a steric interaction with groups on the pyrrolidine ring in 
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the transition state.  The production of spirohydantoin 12 as the major diastereomer of the 
Bucherer-Bergs reaction is consistent with the proposed mechanism. 
3.5 COMPLETION OF THE SYNTHESIS OF 3 
 The hydrolysis of hydantoins such as 12 generally occurs under harsh conditions, NaOH 
or Ba(OH)2, H2O, 100oC, which would destroy the Cbz and t-butyl protecting groups of 13.  We 
reacted spirohydantoin 12 with di-tert-butyl carbonate (Boc2O), and 4-dimethylaminopyridine 
(DMAP) in THF24.  This reaction placed Boc groups on the amide and imide nitrogen atoms of 
the hydantoin to form the more hydrolysable bis-Boc-hydantoin derivative 21 in 74% yield 
(Scheme 13).  The hydrolysis of 21 to form the C4 amino acid was performed in a biphasic 
reaction with 2M KOH and THF at room temperature for 30 minutes.  The free amino acid 
product of the hydrolysis was isolated by precipitation and used without further purification in a 
Schotten-Bauman reaction with N-(9-fluorenylmethoxycarbonyl)-succinamide (Fmoc-OSu) in 
1:1 dioxane:water to yield 22 in 78% yield over two steps.   
The esterification of the C4 acid with dicyclohexylcarbodiimide (DCC), 4-
dimethylaminopyridine (DMAP) and 2,2,3,3-tetrafluoro-1-propanol in dichloromethane (DCM) 
provided 23 in 72% yield.  The synthesis of the 2,2,3,3-tetrafluoro-1-propanyl ester was 
indicated from the incorporation of the pip5(2S5S) monomer 1 into bis-peptide oligomeric other 
bis-amino aicds through the C5 carbonyl was facilitated by the use of the 2,2,3,3-tetrafluoro-
propanylester25. 
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a) Boc2O, DMAP, THF b.) 2M KOH, dioxane c.) Fmoc-Osu, K2CO3 d.) DCC, DMAP, 2,2,3,3 tetrafluoro-1-
propanol (TFPOH) e.) 1:1 TFA:DCM f.) i) H2, Pd/C, THF ii.) Boc2O, DIPEA, DCM 
Scheme 13. Synthesis of the Pip4 (2S4R) Bis Amino Acid 
 
After the esterification at C4 to form 22 was complete, the tert-butyl ester at C2 of 23 
was converted to the carboxylic acid with 1:1 TFA in DCM to form 24 (79% yield).  
Hydrogenolysis of the Cbz group followed by Boc protection with Boc2O provided the final 
monomer 2 in an overall yield of 13.5% (unoptimized) from hydantoin 12. 
3.6 COMPLETION OF THE SYNTHESIS OF 4 
Monomer 3 was developed from the minor hydantoin diastereomer 13.  The conversion 
of 13 into 3 followed the same route as the formation of 2 from 12 (Scheme 14).  The overall  
yield of 3 was 21.8% (unoptimized) from hydantoin 13. 
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Scheme 14.  Synthesis of 4 
3.7 CONCLUSIONS 
I applied a homologation reaction involving the use of trimethylsilyldiazomethane in the 
synthesis of ketones 8 and 9.  While the yield of the trimethylsilyldiazomethane reaction was 
comparable to the method previously employed by Gupta and coworkers, the 
trimethylsilyldiazomethane reaction showed reversed selectivity forming ketone 9 in slight 
excess.  This pattern of yield was reversed from the previously applied homologation method.   
I was able to complete the synthesis of the pip4(2S4R) monomer 2 in 13.5% from 
hydantoin 12.  I also accomplished synthesis of pip4(2S4S) in 21.8% overall yield from 13.  The 
2 and 3 have been characterized and were observed to be stable upon storage for at least one 
month. 
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3.8 EXPERIMENTAL METHODS 
(2S)-4-oxopiperidine-1,2-dicarboxylic acid 1-benzyl ester 2-tert-butyl ester (9) 
Compound 5 (17.25 g, 54.0 mmol) was dissolved in 500 mL of DCM and cooled to -
78oC.  Borontrifluoride etherate (13 mL, 51.3 mmol) was added and the solution stirred for ten 
minutes at which time trimethylsilyl diazomethane was added.  The reaction was stirred at -78oC 
under N2 for 4 hours, allowed to warm to room temperature and saturated aqueous sodium 
bicarbonate was added.  The aqueous layer was washed twice with DCM and the organic layers 
were combined, washed with water twice, dried and concentrated.  The residue was brought up 
in 500 mL methanol and 22.45 g (3.1 mmol) of K2CO3 were added.  The reaction was stirred for 
2 hours, then diluted with 800 mL of water.  The solution was extracted with ethyl acetate twice.  
The ethyl acetate layers were combined, washed twice with 1M HCl, then water and once with 
brine, dried and concentrated.  An automated flash chromatography column was performed 
(gradient 1:4 to 1:2 ethyl aceteate:hexanes) to clean and separate products.  The compounds 8 
and 9 were isolated in 36% overall yield.  After separation compound 8 was isolated as yellow 
oil.  1H NMR (300 MHz, 345 K, DMSO) δ 7.42 ( m, 5H), 5.19 (s, 2H), 4.88 (dd, J = 7.5, 3.9 Hz, 
1H), 4.08 (ddd, J = 14.2, 7.2, 6.9Hz,  1H), 3.69 (ddd, J = 13.3, 8.4, 5.1, 1H), 2.98 (dd, J = 15.9, 
7.5 Hz, 1H), 2.64 (dd, J = 15.9, 3.9 Hz, 1H) 2.55-2.41 (br m, 2H), 1.41 (s, 9H); 13C NMR (75 
MHz, DMSO, 345 K) 204.9, 169.6, 154.4, 136.1, 127.8, 127.3, 127.0, 81.2, 66.3, 54.7, 38.6, 
38.5, 27.1; HR MS (EI) calcd for C13H14N1O3  232.0974 found 232.0967. 
(5S,9R)-2,4-dioxo-1,3,8,triazaspiro[4.5]decane-8,9-dicarboxylic acid 8-benzyl ester 9-tert-
butyl ester (12) 
Compound 9 (10.45 g, 31.3 mmol) was placed in a reaction vessel along with 3.34 g 
(51.2 mmol) potassium cyanide and 16.11 g (167.7 mmol) ammonium carbonate.  Water and 
DMF were added to the reaction vessel (80 ml each) and the vessel was sealed, stirred and heated 
to 70oC for 4 hours.  The vessel was cooled and the reaction mixture diluted with 150 ml water 
and extracted with ethyl acetate (2x 50 ml).  The organic layer was washed with aqueous LiCl 
(1/2 saturated concentration) (2x 25mL) and brine, dried with MgSO4 and concentrated.  A flash 
chromatography column was run on an ISCO automated chromatography system (gradient 1:8 to 
1:2 ethyl acetate in hexanes) to purify and separate the title product and its diastereomer at C4.   
The title compound was crystallized from ethyl acetate/hexanes to yield white needle-like 
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crystals, 6.34g 50.2% yield.  Mp = 105oC (decomp.) ORD [α]D -24.1o(c 0.0359, CHCl3); IR 
(neat):  2980, 2935, 1791, 1785, 1741,1345, 1320, 1252, 1142, 841, 752, 697 cm-1; 1H NMR 
(300 MHz,  DMSO, 345K rotational isomers not fully resolved) δ 10.6 (s, 1H), 7.33 (m, 5H), 
7.15 (s, 1H), 5.15 (d, J = 12.6, 1H), 5.08 (d, J = 12.6, 1H), 4.75 (br s, 1H), 4.00 (d, J = 13.8, 1H), 
3.41 (dd, J = 12.0, 10.5 Hz, 1H) 2.11 (br m, 2H), 1.85 (ddd, J = 13.2, 13.3, 4.8 Hz, 1H) 1.65 (br 
m, 1H) 1.41 (s, 9H ; 13C NMR (75 Mz, DMSO, 345 K) 177.0, 169.8, 156.2, 155.0, 136.3, 127.9, 
127.4, 127.0, 81.3, 66.3, 59.0, 51.8, 36.8, 33.2, 30.9, 27.2; HR MS (EI) calcd for C20H26N3O6 
(M+) 404.1822, found 404.1835. 
(5S,9S)-2,4-dioxo-1,3,8,triazaspiro[4.5]decane-8,9-dicarboxylic acid 8-benzyl ester 9-tert-
butyl ester (13) 
Minor diastereomer of 12 isolated as white glassy solid 1.81 g, 14.3% yield.  ORD [α]D -
13.1o(c 0.0151, CHCl3); IR (neat):  3243, 3066, 2978, 2935, 1779, 1731, 1408, 1341, 1269, 1239, 
1215, 1155,  841, 754, 697 cm-1; 1H NMR (300 MHz,  DMSO, 345K) δ 10.4 (br s, 1H), 7.82 (d, 
J = 6.0 Hz, 1H), 7.43 (m, 5H), 5.18 (d, J = 12.6, 1H), 5.14 (d, J = 12.6, 1H), 4.63 (dd, J = 7.2, 4.5 
Hz, 1H), 3.88 (ddd, J = 9.5, 9.0, 4.5 Hz, 1H) 3.56 (ddd, J = 11.1, 9.5, 3.3 Hz, 1H) 2.30 (dd, J = 
13.8, 4.2 Hz, 1H) 1.93 (m, 2H), 1.67 (ddd, J = 13.2, 11.1, 5.4 Hz, 1H) 1.36 (s, 9H) ; 13C NMR 
(75 Mz, DMSO, 345 K) 176.8, 168.0, 155.4, 154.9, 136.3, 127.9, 127.3, 127.0, 80.5, 78.4, 66.1, 
57.4, 52.7, 37.5, 32.6, 32.0, 27.2; HR MS (EI) calcd for C20H26N3O6Na (M+Na) 426.1641, found 
426.1618. 
 (5S,9R)-2,4-dioxo-1,3,8,triazaspiro[4.5]decane-1,3,8,9-tetracarboxylic acid 8-benzyl 
ester 1,3,9-tri-tert-butyl ester (21) 
Compound 12 (1.79 g, 4.9 mmol), ditert-butyl dicarbonate (2.31 g, 10.6 mmol) and 4-
dimethyl-amino pyridine (36.1 mg, 6.0 mole%) were dissolved in 50 mL of DCM and the flask 
was sealed and stirred under N2 overnight.  The reaction mixture was concentrated and a flash 
chromatography column with a gradient of 1:4 to 1:1 EtOAc:hexanes was performed on an ISCO 
automated chromatography system.  Title compound was isolated as a white foam (2.19g, 74.0% 
yield). ORD [α]D -11.7o(c 0.0239, CHCl3); IR (neat):  2981, 2935, 1826, 1781, 1744, 1456, 
1420, 1370, 1338, 1306, 1252, 1144,  844, 756, 698 cm-1; 1H NMR (300 MHz,  DMSO, 345K) δ 
7.41 (m, 5H), 5.22 (d, J = 12.6, 1H), 5.12 (d, J = 12.6, 1H), 4.44 (dd, J = 12.3, 5.7 Hz, 1H), 3.88 
(ddd, J = 9.3, 9.0, 4.5 Hz, 1H) 3.56 (m, 1H) 2.72 (dd, J = 13.8, 12.3 Hz, 1H) 2.50 (dd, J = 14.1 , 
5.7 Hz, 1H), 2.24 (m, 2H) 1.58 (s, 18H), 1.41 (s, 9H) ; 13C NMR (75 Mz, DMSO, 345 K) 174.2, 
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169.6, 169.4, 154.2, 147.5, 145.8, 144.4, 136.2, 127.8, 127.2, 126.8, 85.2, 83.9, 80.6, 78.6, 66.1, 
60.2, 57.4, 52.7, 38.2, 30.4, 27.3, 27.1, 27.0, 23.2; HR MS (EI) calcd for C25H32N3O8 (M+-
C5H9O2) 502.2189, found 502.2172. 
(2S,4R)-4-(9H-Fluoren-9-ylcarbonylamino)-piperidine-1,2,4-tricarboxylic acid-1-benzyl 
ester 2-tert-butyl ester (22) 
Compound 21 (5.55 g, 9.2 mmol) was dissolved in THF (36 mL).  Potassium hydroxide 
solution (36 mL, 2M) was added and the biphasic solution was stirred vigorously for 2 hours.  
The reaction solution was diluted with 36 ml of ether and the organic and aqueous layers were 
separated.  The ether layer was washed twice with 1% KCl (2x 36 mL).  The aqueous layers 
were combined and cooled to 0oC and 2M HCl was added slowly until precipitate formed.  The 
precipitate was collected by filtration, washed with cold water and dried under vacuum to a white 
powder (3.20 g, 91.9% yield).  Material was used without further purification in the next 
reaction.  The material from the previous reaction (2.52 g, 6.6 mmol) was suspended in 60 mL of 
1:1 H2O:Dioxane to which 11.6 mmol (1.56 g) of potassium carbonate and 2.74 g (8.1 mmol) of 
Fmoc-O-succinate were added.  The biphasic solution became homogenous and was allowed to 
react for 12 hours, after which the reaction solution was diluted with 30 mL of ether.  The 
organic layer was separated and washed twice with 50 mL each of 1 M HCl.  The aqueous layers 
were combined and backwashed with ether 2 x 25 ml.  The combined organic layers were 
washed with brine, dried and concentrated.  Flash chromatography with 3% Methanol in DCM 
with 0.1% HOAc added yielded the title compound, which was crystallized from EtOAc:hexanes 
to give white needles (3.09 g, 78.0% yield).  Mp = 118.4oC   ORD [α]D -14.4o(c 0.0127, CHCl3); 
IR (neat):  3324, 2977, 2935,1713, 1449, 1423,1368, 1341, 1268, 1155, 1065, 758, 741, 698 cm-
1; 1H NMR (300 MHz,  DMSO, 345K) δ 12.20 (br s, 1H) 7.86-7.31 (m, 13H), 7.15 (s, 1H), 5.22 
(br s, 2H), 4.58 (dd, J = 6.9, 1.5 Hz, 1H) 4.38 (dd, J = 7.6, 5.7 Hz, 1H), 3.13 (dd, J = 7.6, 6.9 Hz, 
1H) 3.98 (dd, J = 17.4, 15.2 Hz, 1H), 3.83 (br m, 1H) 3.33 (br m, 1H), 2.91 (d, J = 11.4 Hz, 1H), 
2.22 (dd, J = 14.7, 7.2 Hz, 1H) 2.00 (br m, 1H), 1.68 (ddd, J = 13.4, 13.2, 5.1 Hz, 1H) 1.30 (s, 
9H) ; 13C NMR (75 Mz, DMSO, 345 K) 175.2, 170.4, 156.3, 155.9, 144.5, 144.3, 144.3, 141.3, 
141.2, 137.3, 128.8, 128.2, 128.1, 127.9, 127.6, 127.5, 125.9, 125.6, 125.6, 120.5, 81.4, 56.5, 
52.6, 47.5, 47.3, 37.2, 34.8, 32.5, 30.4, 28.0; HR MS (EI) calcd for C34H36N2O8Na (M++Na) 
623.2369, found 623.2371. 
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(2S,4R)-4-(9H-Fluoren-9-ylcarbonylamino)-piperidine-1,2,4-tricarboxylic acid-4-
(2’,2’,3’,3’)-tetrapropyl ester 1-benzyl ester 2-tert-butyl ester (23) 
Compound 22 (3.09 g, 5.1 mmol), dicyclohexyl carbodiimide (1.69 g, 8.2 mmol), and  4-
dimethylamino pyridine (80 mg,  0.65 mmol) were dissolved in DCM.  To this solution was 
added 916 μL (10.2 mmol) of 2,2,3,3 tetrafluoro-1-propanol.  The reaction was stirred overnight 
under N2.  The solution was filtered and concentrated.  A flash chromatography column was 
performed with 1:3 ethyl acetate: hexanes and the title compound was produced in 72.1% yield 
(2.63 g) as white foam.  ORD [α]D -15.9o(c 0.0377, CHCl3); IR (neat):  3323, 2976, 2935,1708, 
1517, 1450, 1419, 1368, 1271, 1220, 1156, 1107, 1078, 758, 741, 698 cm-1; 1H NMR (300 MHz,  
DMSO, 345K) δ 12.20 (br s, 1H) 7.86-7.31 (m, 14H), 6.43 (ddd, J = 52.2 Hz, 5.1, 5.1 Hz, 1H) 
5.22 (br m, 2H), 4.64-4.54 (m, 5H) 4.14 (m, 2H), 3.88 (br m, 1H), 3.36 (br m, 1H), 2.93 (d, J = 
11.4 Hz, 1H), 2.25 (dd, J = 14.4, 6.9 Hz, 1H) 2.00 (br m, 1H), 1.68 (ddd, J = 13.4, 12.9, 4.8 Hz, 
1H) 1.30 (s, 9H) ; 13C NMR (75 Mz, DMSO, 345 K) 172.7, 170.1, 156.4, 155.9, 144.3, 144.2, 
144.1, 141.3, 141.2, 137.3, 128.7, 128.4, 128.2, 128.1, 127.9, 127.7, 127.5, 127.4, 125.7, 125.5, 
125.4, 120.5, 109.7, 81.5, 67.0, 66.6, 60.7, 57.1, 52.5, 47.4, 47.3, 37.0, 32.3, 30.3, 28.1; HR MS 
(EI) calcd for C37H38F4N2O8Na (M++Na) 737.2462, found 737.2393. 
(2S,4R)-4-(9H-Fluoren-9-ylcarbonylamino)-piperidine-1,2,4-tricarboxylic acid-4-
(2’,2’,3’,3’)-tetrapropyl ester 1-benzyl ester (24) 
Compound 23 (2.06 g, 2.9 mmol) was dissolved in DCM (15 ml), and 15 mL of TFA 
were added to the solution.  The reaction was sealed and stirred under N2 for 6 hours.  The 
reaction solution was concentrated and the residue brought up in 75 mL ether.  The ether solution 
was washed with 1 M HCl  (2x 75 mL), and brine, dried and concentrated.  An automated flash 
chromatography column was run with a gradient of 0-5 %methanol in DCM with 0.1% HOAc 
added.  This yielded the title compound as white foam in 79.5% yield (1.52 g).  ORD [α]D 
+27.7o(c 0.0173, CHCl3); IR (neat):  3271, 3017, 2957, 2935,1760, 1723, 1450, 1414, 1340, 
1270, 1220, 1164, 1108, 1077, 743, 697 cm-1; 1H NMR (300 MHz,  DMSO, 345K rotational 
isomers not fully resolved) δ 12.20 (br s, 1H) 7.86-7.31 (m, 14H), 6.47 (ddd, J = 52.2 Hz, 5.1, 
5.1 Hz, 1H) 5.18 (br s, 2H), 4.77-4.23 (m, 6H) 3.96 (br m, 1H), 3.52 (br m, 1H), 3.05 (d, J = 11.4 
Hz, 1H), 2.27 (dd, J = 14.4, 6.9 Hz, 1H) 2.06 (br m, 1H), 1.77 (ddd, J = 13.4, 12.9, 4.8 Hz, 1H); 
13C NMR (75 Mz, DMSO, 345 K) 171.7, 155.2, 155.0, 143.7, 143.3, 140.4, 140.3, 136.5, 134.7, 
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127.9, 127.3, 127.2, 126.9, 126.6, 124.9, 124.8, 119.5, 109.3, 66.1, 65.9, 59.7, 56.1, 50.9, 46.5, 
36.1, 31.4, 29.6; HR MS (EI) calcd for C33H30F4N2O8 (M+) 681.1836, found 681.1824. 
(2S,4R)-4-(9H-Fluoren-9-ylcarbonylamino)-piperidine-1,2,4-tricarboxylic acid-4-
(2’,2’,3’,3’)-tetrapropyl ester 1-tert-butyl ester (2) 
Compound 24 was dissolved in 20 mL of THF and 150 mg of Pd/C was added the vessel 
was sealed and flushed three times with H2.  The reaction was stirred at balloon pressure under 
H2 for 12 hours.  The Pd/C was removed by filtration through Celite, and the filtrate was 
concentrated.  The residue was brought up in 20 mL of THF and 679.1 mg (3.1 mmol) of di-tert-
butyl dicarbonate was added along with 360 μL of DIPEA.   The reaction was sealed and stirred 
for 4 hours.  When complete the reaction was concentrated brought up in ether and washed with 
1M HCl twice and once with brine.  After drying and concentration the compound was purified 
by automated flash chromatography (0-5% MeOH in DCM with 0.1% HOAc).  Compound 3.8 
was isolated as white foam in 40.9% yield (500.9 mg). ORD [α]D +42.7o(c 0.0217, CHCl3); IR 
(neat):  3271, 3017, 2957, 2935,1760, 1723, 1450, 1414, 1340, 1270, 1220, 1164, 1108, 1077, 
743, 697 cm-1; 1H NMR (300 MHz,  DMSO, 345K) δ 12.15 (br s, 1H) 7.87-7.31 (m, 9H), 6.41 
(ddd, J = 52.2, 5.1, 5.1 Hz, 1H) 4.62-4.43 (m, 3H) 4.27-4.18 (m, 3H), 3.75 (br m, 1H), 3.36 (br 
m, 1H), 2.90 (d, J = 11.4 Hz, 1H), 2.20 (dd, J = 14.4, 6.9 Hz, 1H) 1.98 (br m, 1H), 1.67 (ddd, J = 
13.4, 12.9, 4.8 Hz, 1H) 1.42 (s, 9H) ; 13C NMR (75 Mz, DMSO, 345 K) 172.8, 156.0, 155.2, 
144.5, 144.2, 141.3, 128.1, 127.2, 127.5, 125.7, 120.4, 109.7, 79.8, 66.7, 60.6, 57.0, 51.6, 47.4, 
36.7, 32.4, 30.6, 28.5; HR MS (EI) calcd for C30H32F4N2O8Na (M++Na) 647.1992, found 
647.2020. 
(5S,9S)-2,4-dioxo-1,3,8,triazaspiro[4.5]decane-1,3,8,9-tetracarboxylic acid 8-benzyl ester 
1,3,9-tri-tert-butyl ester (25) 
Compound 13 (0.51 g, 0.1 mmol), ditert-butyl dicarbonate (0.43 g, 0.2 mmol) and 4-
dimethyl-amino pyridine (5.2 mg, 4.8 mole%) were dissolved in 50 mL of DCM and the flask 
was sealed and stirred under N2 overnight.  The reaction mixture was concentrated and a flash 
chromatography column with a gradient of 1:4 to 1:1 EtOAc:hexanes was performed on an ISCO 
automated chromatography system.  Crystallization of 25 from ethyl acetate/hexanes was 
possible to yield white needles. Yield 85.6%. Mp = 155.9oC  ORD [α]D -2.49o(c 0.0117, CHCl3); 
IR (neat):  2981, 2935, 1880, 1781, 1744, 1456, 1420, 1370, 1338, 1252, 1144, 756, 698 cm-1; 1H 
NMR (300 MHz,  DMSO, 345K) 7.34 (br s, 5H), 5.14 (br m, 2H) 4.84 (d, J = 7.5 Hz, 1H), 4.0 
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(dd, J = 14.1, 3.0 Hz, 1H), 3.48 (br m, 1H), 2.77 (br m, 1H), 2.53-2.42 (br m,  2H) 2.04 (br m, 
1H), 1.51 (s, 9H), 1.48 (s, 9H), 1.38 (s, 9H) ; 13C NMR (75 Mz, CDCl3) 168.7, 168.6, 167.9, 
167.6, 155.7, 155.5, 148.3, 147.0, 144.9, 136.3, 128.4, 128.3, 127.9, 127.9, 127.8, 86.7, 85.2, 
82.2, 67.6, 61.1, 52.8, 52.5, 37.2, 28.7, 27.8, 27.6; HR MS (EI) calcd for C30H41N3O10Na 
(M++Na) 626.2690, found 626.2683. 
(2S,4S)-4-(9H-Fluoren-9-ylcarbonylamino)-piperidine-1,2,4-tricarboxylic acid-4-
(2’,2’,3’,3’)-tetrapropyl ester 1-benzyl ester 2-tert-butyl ester (26) 
Compound 25 (3.25 g, 5.2 mmol) was dissolved in THF (25 mL).  Potassium hydroxide 
solution (25 mL, 2M) was added and the biphasic solution was stirred vigorously for 2 hours.  
The reaction solution was diluted with 36 ml of ether and the organic and aqueous layers were 
separated.  The ether layer was washed twice with 1% KCl (2x 36 mL).  The aqueous layers 
were combined and cooled to 0oC and 2M HCl was added slowly until precipitate formed.  The 
precipitate was collected by filtration, washed with cold water and dried under vacuum to a white 
powder.  Material was used without further purification in the next reaction.  The material from 
the previous reaction (1.49 g, 4.4 mmol) was suspended in 30 mL of 1:1 H2O:Dioxane to which 
5.6 mmol (0.78 g) of potassium carbonate and 1.37g (4.6 mmol) of Fmoc-O-succinate were 
added.  The biphasic solution became homogenous and was allowed to react for 12 hours, after 
which the reaction solution was diluted with 30 mL of ether.  The organic layer was separated 
and washed twice with 50 mL each of 1 M HCl.  The aqueous layers were combined and 
backwashed with ether 2 x 25 ml.  The combined organic layers were washed with brine, dried 
and concentrated.  Flash chromatography with 3% Methanol in DCM with 0.1% HOAc added 
yielded the title compound as a clear oil (2.48g,Yield 67%).  ORD [α]D -11.8o(c 0.0122, CHCl3); 
IR (neat):  3323, 2977, 2935, 1759, 1705, 1525, 1450, 1420, 1368, 1268, 1218, 1155, 1107, 845, 
758, 741, 698 cm-1; 1H NMR (300 MHz,  DMSO, 345K rotational isomers not fully resolved) δ 
7.86-7.30 (m, 14H), 6.39 (ddd, J = 52.2 Hz, 5.1, 5.1 Hz, 1H) 5.10 (br m, 2H), 4.49-4.32 (m, 7H) 
4.20 (br m, 1H), 3.75 (br m, 1H), 3.27 (br m, 1H), 2.56 (br m, 1H), 2.20-2.15 (br m, 2H) 1.67 (br 
m, 1H), 1.36 (s, 9H) ; 13C NMR (75 Mz, DMSO, 345 K) 170.9, 169.1, 154.9, 154.7, 143.3, 
140.4, 136.3, 127.8, 127.3, 127.1, 127.0, 126.5, 124.5, 119.5, 108.7, 80.7, 66.1, 65.4, 59.7, 55.4, 
52.6, 37.6, 31.9, 31.0, 27.2; HR MS (EI) calcd for C37H38F4N2O8Na (M++Na) 737.2462, found 
737.2437. 
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(2S,4R)-4-(9H-Fluoren-9-ylcarbonylamino)-piperidine-1,2,4-tricarboxylic acid-4-
(2’,2’,3’,3’)-tetrapropyl ester 1-benzyl ester (27) 
Compound 26 (1.54 g, 2.5 mmol), dicyclohexyl carbodiimide (0.85 g, 4.1 mmol), and  4-
dimethylamino pyridine (40 mg,  0.32 mmol) were dissolved in DCM.  To this solution was 
added 916 μL (10.2 mmol) of 2,2,3,3-tetrafluoro-1-propanol.  The reaction was stirred overnight 
under N2.  The solution was filtered and concentrated.  A flash chromatography column was 
performed with 1:3 ethyl acetate:hexane and the title compound was produced in as white foam 
(1.54 g, yield 90.2%).  ORD [α]D +12.6o(c 0.0165, CHCl3); IR (neat):  3308, 3034, 2940, 1758, 
1716, 1450, 1425, 1359, 1268, 1218, 1187, 1108, 1077, 758, 743, 698 cm-1; 1H NMR (300 MHz,  
DMSO, 345K rotational isomers not fully resolved) δ 12.20 (br s, 1H) 7.86-7.33 (m, 14H), 6.38 
(ddd, J = 52.2 Hz, 5.1, 5.1 Hz, 1H) 5.14 (br s, 2H), 4.58-4.19 (Br m, 6H) 3.82 (br m, 1H), 3.33 
(br m, 1H), 2.55 (Brm, 1H), 2.26-2.05 (Br m, 1H) 1.97-.174 (br m, 3H), 1.25 (Br m, 1H); 13C 
NMR (75 Mz, DMSO, 345 K) 171.2, 170.8, 154.9, 154.8, 143.4, 143.3, 140.4, 136.4, 127.9, 
127.3, 127.1, 126.9, 126.6, 124.6, 119.6, 108.8, 66.1, 65.4, 59.5, 55.4, 51.8, 47.3, 46.5, 37.7, 
32.9, 31.4; HR MS (EI) calcd for C33H30F4N2O8 (M+) 681.1836, found 681.1840. 
(2S,4S)-4-(9H-Fluoren-9-ylcarbonylamino)-piperidine-1,2,4-tricarboxylic acid-4-
(2’,2’,3’,3’)-tetrapropyl ester 1-tert-butyl ester (3) 
Compound 27 (1.03 g, 1.8 mmol) was dissolved in DCM (7 ml), and 7 mL of TFA were 
added to the solution.  The reaction was sealed and stirred under N2 for 6 hours.  The reaction 
solution was concentrated and the residue brought up in 40 mL ether.  The ether solution was 
washed with 1 M HCl  (2x 40 mL), and brine, dried and concentrated.  An automated flash 
chromatography column was run with a gradient of 0-5 %methanol in DCM with 0.1% HOAc 
added.  This yielded the title compound as white foam  Yield over 2 steps 60.0% (0.68 g). ORD 
[α]D -4.8o(c 0.0121, CHCl3); IR (neat):  3324, 3017, 2932, 2856, 1755, 1704, 1525, 1450, 1415, 
1367, 1253, 1178, 1108, 758, 742, 698 cm-1; 1H NMR (300 MHz,  DMSO, 345K, rotational 
isomers not fully resolved) δ 12.15 (br s, 1H) 7.87-7.31 (m, 14H), 6.39 (m, 1H) 4.62-4.18 (m, 
6H), 3.65 (br m, 1H), 3.09 (br m, 1H), 2.10 (br m, 1H), 1.65 (br m, 1H) 1.98 (br m, 1H), 1.38 (br 
s, 9H), 1.20 (βρ μ, 2Η) ; 13C NMR (75 Mz, DMSO, 345 K) 171.1, 155.0, 143.3, 140.4, 128.4, 
127.8, 127.1, 126.8, 126.5, 124.5, 119.5, 109.7, 66.1, 59.7,  47.2, 46.4, 32.9, 27.5, 28.5. 
 
 52 
4.0  APPLICATION OF RESIDUAL DIPOLAR COUPLINGS TO THE 
DETERMINATION OF BIS-PEPTIDE OLIGOMER SOLUTION STRUCTURE 
4.1 INTRODUCTION 
In the bis-peptide approach (Chapter 1) to macromolecular synthesis all monomers are 
linked covalently through pairs of amide bonds to create spiroladder oligomers4-8.  The shape of 
the oligomer is dependent upon the monomers included in the sequence, the stereochemistry and 
conformation of the monomers, and the order in which the monomers occur in the sequence7.  
Due to the covalently bonded, poly-cyclic nature of the oligomers, the conformations available to 
bis-peptide oligomers are limited when compared to polypeptides and other more flexible 
macromolecules.   
In order to develop applications for bis-peptides, it is valuable to be able to determine the 
solution structures of bis-peptide oligomers.  Our research in this area has made use of ROESY 
NMR spectroscopy4,5,7,8,26,27, double electron-electron resonance (DEER) experiments28 and 
fluorescence energy transfer experiments (FRET)6 to obtain information about the structure and 
flexibility of bis-peptides. 
ROESY NMR spectroscopy has taught us4-8 the preferred conformations of individual 
rings from NOE correlations of 1H atoms.  For each monomer within an oligomer there are 
typically only a small number of  ROESY correlations, generally between zero and three.  Often 
potential correlations are obscured by overlap with other signals and overlap with the solvent 
peak further reducing the data available to determine solution structure; thus ROESY 
spectroscopy alone provides few constraints for structure determination. 
The use of ROESY spectroscopy and residual dipolar couplings (RDCs) in structure 
determination is complementary, and the use of both techniques can provide a greater number of 
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constraints to the possible conformations of a molecule than either one alone.  With a greater 
number of constraints, we can feel more confident in our identification of the solution structure 
of a bis-peptide.     
ROESY spectroscopy provides distance information concerning the hydrogen atoms 
within a molecule.   A correlation between hydrogen atoms indicates that the atoms are in close 
proximity to each other, generally within 4 Angstroms.  The intensity of the observed 
correlations can be used to filter a set of reasonable conformational models by constraining the 
distance between pairs of hydrogen atoms.  The possibility of small errors in the intensity 
measurement of the NOE signals could place the correlated atoms at improper distances from 
each other.  The cumulative effect of the errors in distance may lead to the interpretation of an 
improper conformation.  The distance information provided by ROESY spectroscopy can be 
supplemented by the measurement of RDCs, which provide information on the orientation of an 
internuclear vector with respect to the magnetic field of a nuclear magnetic resonance (NMR) 
spectrometer.  Residual dipolar coupling values arise from the interaction of two dipolar nuclei 
within a molecule if molecular rotation is partially impeded in an ordered fashion within the 
magnetic field of a nuclear magnetic resonance (NMR) spectrometer.   
Organic chemists have begun to utilize RDC’s for structural determination only within 
the last five years29-34.  A delay from its use in structural biology35 ensued largely due to the lack  
of suitable NMR alignment media that were soluble in organic solvents.  Most studies to date 
have been performed to distinguish between diastereotopic geminal protons31-34 in molecules 
with little conformational flexibility.  However, Bush and coworkers36,37 have reported the use of 
residual dipolar couplings and ROESY spectroscopy as constraints to filter libraries of 
conformational models to determine the solution conformation of short oligosaccharides. 
In the past our group has used ROESY spectroscopy alone4-8 to filter a set of candidate 
structures to determine the solution structure of bis-peptides.  In the first portion of this chapter, I 
report the first use of residual dipolar coupling supported by ROESY spectroscopy to filter a set 
of DFT refined conformations to determine the solution phase structure of bis-peptide 1 (Figure 
18).  We determined that we can measure the RDC values for the C-H bonds in the cyclic 
backbone of 1, and that the RDC values can be used to identify a single, model of 1 that fits best 
to the collected RDC data.  Our modeling of 1 was independent of constraints derived from 
NMR spectroscopy data.   
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Figure 18.  Structure of pro4(2S4S)-pro4(2R4R)-pro4(2S4s)-Tyr 
 
The second portion of the chapter details the solution structure determination of a second 
bis-peptide oligomer by ROESY spectroscopy alone.  
4.2 RESIDUAL DIPOLAR COUPLING STUDIES OF BIS-PEPTIDE OLIGOMER 
PRO4(2S4S)-PRO4(2R4R)-PRO4(2S4S)-TYR  
Residual dipolar couplings (RDCs) are of most value when the molecule maintains a 
single conformation in solution, as each conformation present in a dynamic ensemble will give 
rise to different a different set of RDC values for each set of interacting dipolar nuclei.  The 
observed value of the RDCs will be a weighted average dependent upon the populations of the 
conformations in the ensemble.  The interpretation of such a set of RDCs becomes more difficult 
with the number of different conformations present in the ensemble.   
My study involved the measurement of RDCs between naturally abundant 1H and 13C 
atoms bonded to one another.  In the context of 1H-13C bonds, RDC values contain information 
on the orientation, with respect to the NMR magnetic field Bo, of the 1H-13C bonds for which 
RDCs have been determined.  By constraining the orientations of the C-H bonds within a 
molecule to a single frame of reference, RDCs also constrain the orientation of the bonds to one 
another even if the bonds are remote in covalent structure and distance.  The constraints on bond 
orientation provided by RDCs provide a powerful tool to determine the solution phase structure 
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of a molecule, as the orientations of the bonds within a molecule are altered with respect to one 
another between conformations. 
The measurement of residual dipolar coupling requires molecular rotation to be partially 
impeded.  The impediment to rotation, called an alignment medium, must have a single 
orientation with respect to Bo.  Common alignment media are solutions of liquid crystals in 
aqueous samples38,39 or strained gels in the case of molecules soluble in organic solvents40.  The 
alignment medium ensures that the molecule tumbles in an anisotropic manner, which means all 
of the orientations of the molecule with respect to the spectrometer magnetic field Bo are not 
equally likely.  Alignment media must be chosen to weakly align the small molecule so as to 
create dipolar coupling values that would be about 1/10,000 of the solid state values41.  The 
alignment medium used in my study was a 10mg/ml solution of Pf1 phage in D2O39.  The aligned 
phage particles interact with the molecule to impede its tumbling, and do not contribute to the 
NMR spectrum because they do not tumble.  The phage NMR signals are broadened into the 
baseline due to extremely fast T2 relaxation. 
 
 
A.) The magnetic field generated by a dipolar, magnetically active nucleus P.  B.) The P nuclear magnetic field can 
have a shielding or deshielding effect on a nearby nucleus Q with respect to the applied magnetic field Bo.  C.) The 
effect of the nuclear magnetic field on a nearby magnetically active nuclei is dependent upon the angle θ between 
the internuclear vector PQ or QP and the applied field; this type of coupling is called dipolar coupling. 
Figure 19 
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A dipolar nucleus, P, generates a local magnetic field (Figure 19).  If P is placed in a 
strong magnetic field Bo, such as in an NMR spectrometer, its magnetic field aligns with the 
external field. The magnetic field experienced by another nearby, dipolar nucleus Q is the sum of 
the P nuclear field at Q and the external field Bo; this is termed dipolar coupling.  The magnitude 
of dipolar coupling is related to the inverse cube of the distance between the nuclei and the angle 
the internuclear vector makes with Bo; when P and Q atoms are bonded to each other the 
internuclear vector is the bond between the atoms.  If a crystalline solid was placed in an NMR 
spectrometer, the orientation of the PQ bond would be held constant with respect to the external 
field and the magnitude of dipolar coupling would be described by Equation 1. 
 
Equation 1 DPQ = DPQmax (3cos2θ-1)/2 
 
Where θ is the angle between the internuclear vector and Bo, and DPQmax is: 
 
Equation 2 DPQmax = -μo (h/2π) γPγQ / (4π2r3PQ). 
 
The term μo is the permittivity of vacuum, h is Planck’s constant γP and γQ are the magnetogyric 
ratios of P and Q respectively an rPQ is the distance between the nuclei.  The value of the dipolar 
coupling in the case of a 1H-13C bond in a solid can be on the order of 60 KHz.   
When dissolved in solution the molecule tumbles, and the orientation of the PQ bond 
with respect to Bo is not constant but varies with time and from molecule to molecule.  The value 
of the dipolar coupling can be described in this case by Equation 3. 
 
Equation 3 DPQ = DPQmax <(3cos2θ-1)/2> 
 
The brackets <> in Equation 3 indicate the average of the term (3cos2θ-1/2) over time.  In 
the case of isotropic tumbling, the <(3cos2θ-1/2)> term averages to zero, and the dipolar 
coupling is not observed in the NMR spectrum.  If a molecule is partially aligned it no longer 
tumbles isotropically and it becomes “partially aligned”.  In a partially aligned situation, some 
orientations of the molecule with respect to Bo become more probable than others and a portion 
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of the dipolar coupling, called residual dipolar coupling can be observed.  A set of residual 
dipolar couplings for a molecule can be calculated in terms of Equation 4: 
 
Equation 4 ∑=
lk
lkklijij SrDD
,
3
max )cos()cos(/ θθ  
 
Here Skl contains information about the partial alignment of the molecular coordinate axes with 
respect to Bo, and the cosine terms relate the internuclear vectors of the bonds to the molecular 
coordinate axes.  The value of an RDC is determined from a pair of NMR spectra, and the 
directional cosines are obtained from the conformational model leaving the partial alignment of 
the molecule be calculated.  A complete description of the partial alignment of the molecule is 
called the alignment tensor, S.  The calculation of the alignment tensor requires a set of at least 5 
measured, non-degenerate residual dipolar couplings and the coordinates of the interacting nuclei 
from a conformational model.   
In this study, the calculation of alignment tensors was performed using the REDCAT 
program developed by Prestegard and coworkers42.  The input for REDCAT is the set of at least 
5 experimentally determined RDC values, an error range for each RDC value, εij, and the 
coordinates of the interacting nuclei.  The model structure is used to determine the internuclear 
distance for each bond and to create a matrix, A, of direction cosines which relate the individual 
internuclear vectors to the molecular coordinate system. 
A set of RDCs, b can be calculated from the matrix A and an alignment tensor S using 
matrix multiplication (Equation 5) 
  
Equation 5  b = AS. 
   
REDCAT uses singular value decomposition to determine the left pseudo-inverse of A, 
A-1 as a real matrix.  If both sides of Equation 5 are multiplied by A-1, S can be calculated. 
 
Equation 6  S = A-1b 
 
The alignment tensor S is converted into a 3x3 matrix that can be diagonalized resulting 
in a set of three eigenvalues and eigenvectors.  The eigenvalues are sorted and assigned the terms 
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Axx, Ayy, and Azz such that Azz has greatest magnitude and Axx has the lowest magnitude. The 
diagonalization also produces three eigenvectors which are the x, y, and z axes of a new 
coordinate system called the principle axis system (PAS) of the molecule.  The values of Axx, 
Ayy, Azz are the probability that the PAS x, y, z axes of the molecule will align with the 
direction of the external field B0.  
Once an alignment tensor, S, is calculated by REDCAT it can be used to determine a 
predicted set of RDC values, bpredicted, from the structure matrix A (Equation 7). The fit between 
bpredicted and the measured RDC values, b is calculated as the root mean square difference 
(RMSD) between the values.   
 
Equation 7  bpredicted  =  AS 
 
Calculate S’= A-1b’  
Calculate bpredicted 
bpredicted = AS’ 
Calculate RMSD of 
bpredicted wrt bexp  
 
S’ with lowest 
RMSD is the best fit 
alignment tensor 
Generate perturbed 
RDC value set b’ 
Repeat 
until 
maximum 
number of 
iterations 
has been 
reached 
Find A-1 for AS=b 
by singular value 
decomposition
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 20.  Flowchart of the REDCAT Process for the Calculation of Best Fit Alignment Tensor 
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 Due to uncertainty in the measured RDC values, multiple alignment tensors S’, are 
calculated iteratively from perturbed sets of RDC values, b’ (Equation 8) 
 
Equation 8 S’ = A-1b’ 
 
The sets of perturbed RDC values are obtained by random variation of each input RDC 
within the error range ±εij, which is given to REDCAT as user defined input ( 
Figure 20).  All alignment tensors calculated are evaluated for their ability to predict the 
input set of RDCs (Equation 9) 
 
Equation 9 bpredicted’ = AS’  
 
The best fit alignment tensor for the input RDCs will be the alignment tensor which has the 
lowest RMSD between bpredicted’ and the measured RDC values, b.  The best fit alignment tensor 
for the conformational model and the input RDCs is reported by REDCAT.  REDCAT can also 
report the values of the predicted RDCs from the best fit alignment tensor and the 
conformational model.  We assess the fit of a conformational model to the measured RDC data  
 
 
The conical regions of space where the internuclear vector PQ , or its inverse QP could lie.  Note the appearance of 
the cone is not circular, but ovoid. Copied from ref 41 
Figure 21.  Conical Region of Space Containing Internuclear Vectors 
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 by comparing the RMSD fit between the RDCs predicted by the best fit alignment tensor and the 
measured RDCs.  A model which does not correctly predict the bond orientations within the 
solution phase structure will predict RDCs that do not match the measured RDCs. 
If the coordinates of the internuclear vectors are given in polar coordinates with respect to 
the PAS, equation 4 can be rewritten as Equation 10 which can be used to predict the value of a 
residual dipolar coupling. 
 
Equation 10 ( ) ( )[ ]yyxxZZPQPQ AAADD −+= φθθ 2cossincos34/3 22max  
 
This equation predicts that a residual dipolar coupling value may arise from the 
orientation of the PQ bond anywhere on a conical section of space.  The internuclear vectors PQ 
and QP produce the same value for a residual dipolar coupling so the region of space where the 
bond could lie is described by two conic sections.  Additionally, these conic sections of space are 
not circular, but are distorted due to the higher probability of molecular alignment along the 
molecular y axis over the molecular x axis (Figure 21).  Equation 10 tells us that a single RDC 
value only constrains a bond vector to lie somewhere on these two conical sections of space but 
it does not constrain it within the conical section of space. This is a fundamental limit on the 
structural information provided by a single RDC value with regards to the orientation of a single 
bond.  
The REDCAT program has the ability to use summed RDC values of methylenes in its 
analysis; this feature became important to us because we obtained the least error in our 
measurements when we measured RDC values in the carbon (F1) dimension of the HSQC 
spectrum.  In the case of a methylene unit, a carbon with two attached hydrogens Ha and Hb the 
value in Hertz obtained from the resonance splitting in the unaligned HSQC spectrum is the sum 
1JCHa +1JCHb  and the value in Hertz obtained from the resonance splitting in the aligned HSQC 
spectrum is the sum 1JCHa + 1DCHa+1JCHb + 1DCHb.  The difference between these two splittings is 
the sum of the two RDCs 1DCHa+1DCHb. This is a fundamental limitation in our ability to measure 
RDCs that arises because we are measuring the splittings in the carbon (F1) dimension. The 
consequence of this limitation is that we have fewer RDCs available for refinement and we had 
to learn how to deal with the added complexity of summed values of RDCs.  For instance, we 
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were not able to figure out how to configure the commonly used residual dipolar coupling 
software PALES43 to deal with summed values of RDCs.  However, we did learn how to deal 
with these values using REDCAT.  This problem only arises for us because we are measuring 
RDC values between carbon and hydrogen and most of our carbons are methylenes; this is not a 
problem for methines and we don’t have methyl groups (and we would ignore them if we did).  
In NMR structure determination of biomolecules this problem does not arise; RDCs are 
commonly measured between 15N atoms and their attached 1H atoms of amide bonds, and alpha 
carbons and their attached hydrogen atoms (methines). The structure refinement program 
XPLOR does support summed RDC values.  
4.3 DATA COLLECTION 
Our approach to structure determination was to compare measured RDC values to the 
residual dipolar couplings predicted through the use of REDCAT of a small collection of 
chemically reasonable models of 1.  The chemically reasonable models of 1 were generated in a 
stochastic search44 utilizing the AMBER 9410 force field in the molecular modeling program 
MOE9 and further refined by DFT calculations (Becke3LYP/6-31g* level of theory). The goal 
was to determine if there was a single conformation that fit the RDC data well.  We were also 
interested in determining if the lowest energy model corresponded to the model that gave the 
best fit of predicted and experimental RDC’s. 
Prior to the measurement of RDC’s the assignment of all proton and carbon resonances 
was performed based on TOCSY, HMBC and ROESY spectral data (spectra are available in the  
Appendix, see experimental data for sample preparation) including the assignment of individual 
diastereotopic geminal protons. 
The measurement of the RDC values was accomplished by comparing the differences of 
the resonance splitting seen in two 1H-13C coupled HSQC (Heteronuclear Single Quantum 
Coherence) spectra:  one spectrum collected on a sample of 1 without phage added and one 
collected from a sample of 1 with 10mg/ml Pf1 phage solution added (Pf1 phage solution was 
obtained from Asla Biotech and suspended in pH 7.5, 50 mM phosphate buffered D2O).  The 
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phage free sample was used to measure the 1JCH (one bond J coupling between 13C and 1H atoms) 
values for the C-H bonds in the cyclic backbone, C3-C26, of 1, and the phage containing sample 
was used to measure the 1JCH + 1DCH (the sum of the J coupling and the one bond dipolar 
coupling between 13C and 1H atoms) values for the same C-H bonds (spectra are available in the 
Appendix, see experimental data for sample preparation).  The difference in Hertz between the 
1JCH coupling and the 1JCH+1DCH coupling was the value of the residual dipolar coupling. 
The measurement of RDC’s in organic molecules has often been performed by measuring 
the CH coupling in the more densely sampled F2 (1H) dimension30-34.  In this method of HSQC 
experimentation 1JCH and 1DCH coupling is allowed to build during the signal acquisition by 
turning off the decoupling pulses (Figure 22).  Unfortunately our experience was that the 
alignment medium caused severe line broadening in the 1H (F2) dimension (Figure 23) 
preventing the accurate measurement of the RDC values. 
 
 
 
Eliminated for F1 coupling 
Turned off for 
F2 coupling 
Figure 22  Pulse Sequence of the HSQC NMR Experiments 
 
As can be seen in the spectra in Figure 23c, the line broadening of the aligned sample 
caused the loss of all proton-proton J-coupling from the resonance and resulted in a broad peak.  
This hampered our ability to obtain accurate RDC values (less than estimated 1Hz error) from 
the spectrum (Table 4).   
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A.)                                                                                      B.) 
 
26H 
13Hα + 13Hβ 
Overlapped 
13Hα + 13Hβ 
Overlapped 
26H
   
18H 6Hα    6Hα    
   
18H 
C.) 
 
 
 
142.5Hz  
1JCH 
153 Hz 
1DCH +1JCH 
A.) The region from f2 3-5ppm and f1 50-60 ppm of the unaligned F2 coupled HSQC of 1.  B.)  Identical spectral 
region of HSQC from the 10mg/ml phage aligned sample.  C.)  Overlays of one dimensional slices of the 11Ha 
resonance form the unaligned HSQC spectrum (red) and the same slice from the aligned HSQC (blue).  Note the 
loss of the fine structure of the blue peaks making it impossible to determine the 1DCH+1JCH value to the ~1Hz 
accuracy required.  All spectra were obtained on a Bruker 800 MHz NMR equipped with a cryoprobe. 
Figure 23.  Sample F2-HSQC NMR Spectra 
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Table 4.  RDC Values for CH bonds in 1 as Measured in the F2 Coupled HSQC 
 
F2 Dimension Couplings Resonance 
1JCH + 1DCH (Hz) 1JCH (Hz) 1DCH (Hz) Error 
3H-3C 144.8 143.8 0.9 > 1Hz 
4Ha-4C 137.5 140.0 -2.5 > 1Hz 
4Hb-4C 133.2 133.4 -.02 >1Hz 
6Hb-4C 146.1 141.3 4.8 > 1Hz 
11Ha-11C 153.5 142.5 11.0 > 1Hz 
11Hb-11C 147.2 133.2 14.0 > 1Hz 
18H-18C 152.4 146.0 6.4 > 1Hz 
19Ha-19C 137.5 140.0 -2.5 > 1Hz 
19Hb-19C 138.5 134.1 4.4 > 1Hz 
21Ha-21C 148.0 142.8 5.2 > 1Hz 
21Hb-21C 156.9 143.3 13.6 >1 Hz 
26H-26C 129.0 151.9 -22.9 > 1Hz 
 
4.4 F1 (13C) DIMENSION MEASUREMENT OF RDC DATA 
To achieve better spectral resolution the 1H-13C coupled HSQC pulse sequence was 
modified to eliminate the 180o pulse on the 1H channel during the t1 evolution period and 
decoupling was performed during signal acquisition (2k data points in the F1dimension zero 
filed back to 2k for a resolution of 2.94 Hz/point and 4k data points in the F2 dimension).  The 
collection of HSQC spectra in this manner allowed the measurement of the coupling values in 
the 13C (F1) dimension where line broadening was diminished and had less of an impact upon 
RDC measurement (Figure 24).  The coupling values were obtained from one dimensional slices 
of the two dimensional dataset (Table 5). 
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 Table 5.  Residual Dipolar Coupling Values Measured in F1 (13C) Dimension 
 
F1 Dimension Coupling Resonance 
1JCH + 1DCH (Hz) 1JCH (Hz) 1DCH (Hz) Error 
3H-3C 144.4 144.7 -0.28 ±0.5 Hz 
4Ha-4C +4Hb-4C 269.0 271.0 -1.99 ±0.5 Hz 
6Ha-6C + 6Hb-6C 292.1 287.6 4.57 ±0.5 Hz 
10H-10HC 152.3 147.3 5.00 ±0.5 Hz 
11Ha-11C + 11Hb-11C 310.3 296.6 13.74 ±0.5 Hz 
13Ha-13C + 13Hb-13C 299.3 276.9 22.35 ±0.5 Hz 
18H-18C 155.0 146.9 8.06 ±0.5 Hz 
19Ha-19C + 19Hb-19C 275.4 277.0 -1.62 ±0.5 Hz 
21Ha-21C + 21Hb-21C 301.3 297.7 3.58 ±0.5 Hz 
26H-26C 135.8 148.8 13.01 ±0.5 Hz 
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10H     18H 
26H 
13Hα + 13Hβ 
6Hα + 6Hβ 
10H         18H 
26H 
13Hα + 13Hβ 
6Hα + 6Hβ 
 
 
296.65 Hz 
1JCHα + 1JCHβ 
 
 
1JCHα + 1JCHβ+ 1DCHα + 1DCHβ 
310.39 Hz 
HSQC spectrum without phage solution added and with phages solution added, along with an overlay one a 
one dimensional slice of the 11Hb-11C resonance  
Figure 24 Sample F1-HSQC NMR Spectra 
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4.5 RANKING OF CONFORMATIONAL SEARCH MODELS’ FIT TO RDC DATA 
As a first search of the conformational space of 1, we generated a library of 30 plausible 
conformers representing structures that contained envelope conformation changes for all three 
pyrrolidine rings in 1.  This was carried out using a stochastic search44 with the Amber 9410 force 
field within the MOE9 molecular modeling package.  The lowest energy structure from the 
AMBER 94 force field prediction in MOE was submitted to DFT refinement, as were seven 
other models.  Within this eight member library of structures were models that contained the 
most reasonable conformations of the three pyrrolidine rings of 1.  From the modeling done with 
the AMBER 94 force field, each pyrrolidine ring was found to exist in two envelope 
conformations, and the envelope changes were the most likely conformational changes in 1. 
   
A.  
 
              B. 
. 
Figure 25 DFT Models of 1 
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Figure 26 Relative Energy of DFT Refined Structures and RMSD Fit to RDC Data 
 
The structures in the library were named corresponding to the lowest energy AMBER 94 
structure: the lowest structure was labeled “aaa”, the structure which contained a change in the 
envelope of the pyrrolidine ring containing C5 was labeled baa.  Similar names were given to the 
other conformers used in the DFT calculations, where each change of a pyrrolidine ring 
conformation containing C5, C10 or C20 was noted in the as a change from the letter a to b in 
the three letter code respectively (as an example the flipped conformation at C10 only would be 
labeled “aba”). 
The eight DFT optimized structures are shown overlaid in Figure 25a.  Figure 25b shows 
the best fit DFT model structure (RMSD = 1.82, Figure 26).  This model was also calculated by 
DFT calculations to be the lowest energy conformer of 1.  A graph of the correlation of measured 
RDC values to those calculated from the DFT best fit structure is seen in Figure 27.   
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Figure 27 Correlation Chart of Measured versus Calculated RDC Values for Best Fit DFT Structure 
4.6 COMPARISON TO ROESY DATA 
The best bit conformer structure as determined by residual dipolar coupling shown in 
Figure 25b is overlaid with ROESY correlations observed in the spectrum of 1.  The observed 
correlations are consistent with the RDC best fit structure. 
The ROESY spectrum of 1 displayed correlations between the N8 amide proton and one 
each of the geminal C4 and C6 hydrogen atoms.  This relationship allowed the facial assignment 
of the geminal C4 and C6 hydrogen atoms, as the amide N8 stereochemistry was set prior to 
incorporation into the oligomer.   The geminal C4 and C6 hydrogen atoms that had ROESY 
correlations with the N8 amide proton also were observed to have transanular ROESY 
correlations with each other.  The observed correlations indicated that the pyrrolidine ring 
containing C4 and C6 was in the envelope conformation seen in Figure 28a. This conformation 
corresponds to the conformation of this ring in the lowest energy model.  A model of the flipped 
conformation of same pyrrolidine ring can be seen in Figure 28b.  This conformation of the 
pyrrolidine ring was only seen in models of 1 which did not fit well to the ROESY or RDC data, 
and were calculated to be higher in energy than the best fit model.  In Figure 28b, there appears 
to be a closer approach of the N8 amide proton and the C2 carbonyl.  We have reasoned this 
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approach may increase the steric interaction of these groups making this envelope a higher 
energy conformation.  
 
A.)      B.) 
  
A.)  A model of the preferred conformation of a pyrrolidine ring of a pro4(2S4S) monomer in 2 with ROESY 
correlations overlaid.  B.)  A model of the “b” conformation of the pyrrolidine ring of a pro4(2S4S) monomer. 
Figure 28. Conformations of the Pyrrolidine Ring in Pro4(2S4S) monomer 
 
A similar set of correlations was observed in the ROESY spectrum of 1 for the 
pyrrolidine ring containing C11 and C13.   We again interpreted these results to indicate the 
pyrrolidine ring containing these atoms appeared to prefer to reside in an envelope conformation 
which limited steric interaction between the N16 amide proton and the C10 carbonyl.  These 
conformational findings were also consistent with ROESY data collected on other bis peptides4-8. 
4.7 CONCLUSIONS 
 We were able to use HSQC NMR experiments to measure residual dipolar coupling 
values for the 13C-1H bonded atoms in the backbone of 1.  Our calculations showed that the 
lowest energy conformation calculated by DFT had the greatest correlation to the RDC values 
measured for 1; the measured and calculated RDC values for the best fit DFT model, “aaa”, of 1 
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had an RMSD of 1.82.  The models calculated to have the next lowest energies, “aab” and “aba”, 
had RMSD fit values of 3.27 and 7.20 respectively.  In solution, compound 1 will be dynamic 
however our experiments suggest that it spends most of its time in the “aaa” conformation which 
is the lowest energy conformation according to DFT calculations and the conformation most 
consistent with the observed RDCs. 
The intent of this project was to determine if RDC measurements in conjunction with 
molecular modeling could be used to aid in the solution structure determination of bis-peptide 1.  
We feel confident that since the measured RDC values in 1 included data about the internuclear 
vectors of all C-H bonds in the polycyclic backbone of 1, we have been able to identify a 
probable solution phase structure of 1.  Our interpretation is reinforced by the fact that this model 
is also consistent with the ROESY correlations observed in 1. 
The benefits of RDCs are that they provide additional NMR constraints for the structure 
determination of bis-peptide oligomers.  RDC constraints are complementary to ROESY 
constraints in that they provide information on the angular relationship between C-H bonds 
within a molecule while ROESY constraints provide distance information between pairs of 
hydrogen atoms that are physically close to each other.  In this way, RDCs provide more 
“global” structural information complementing the more “local” structural information provided 
by ROESY correlations.  As we synthesize longer, more complex bis-peptides the likelihood of 
overlapped resonances or ambiguous ROESY correlations will increase.  The use of RDC 
constraints to supplement ROESY constraints will allow the structure determination of larger 
bis-peptides. 
4.8 NMR STUDY OF THE BIS-PEPTIDE SEQUENCE PIP5(2S5R)-PIP5(2R5S)-
PRO4(2S4S)-TYR 
We designed a curved scaffold to be used for bifunctional catalyst development.  Our 
approach is to develop curved scaffolds that can hold two functional groups, one on each end of 
the oligomer, close to each other in space.  The scaffold consisted of the monomer sequence 
pip5(2S5R)-pip5(2R5S)-pro4(2S4S)-Tyr7, 2 (Figure 29). It was necessary to determine the 
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sequence’s solution structure to ensure its curved conformation.  To accomplish this, traditional 
two dimensional NMR correlation experiments were employed and compared to computer 
models of the oligomer generated using a stochastic conformational search44 with the MOE9 
molecular modeling program utilizing the AMBER 9410 force field. I also helped initiate the 
determination of the solution structure of this molecule using residual dipolar couplings. 
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Figure 29.  ChemicalStructure of the pip5(2S5R)-pip5(2R5S)-pro4(2S4S)-Tyr Sequence 
4.9 ASSIGNMENT OF 1H AND 13C RESONANCES IN 2 
The first step in the determination of the structure of 2 was to assign all of the 1H and 13C 
resonances.  This determination included the assignment of diastereotopic methylene hydrogens. 
A solution of 2 (10.4 mM) was prepared in 10% D2O in H2O, buffered to pH 3.45 with acetic 
acid-d4/ ammonium acetate-d7 buffer.  The collection of TOCSY (total correlation spectroscopy), 
HMBC (heteronuclear multiple bond correlation spectroscopy), and ROESY (rotating frame 
Overhauser enhancement spectroscopy) spectra was performed at 4oC to shift the residual water 
peak downfield and away from the spectral region where the monomers’ α protons generally 
appear (approx. 4.6 ppm). 
 The TOCSY spectrum allowed the assignment of protons to the spin systems within 2 
(Figure 30), while the HMBC spectrum allowed the assignment of the C-H and C-C connectivity 
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of the monomers.  Additionally the HMBC allowed the inter-residue connectivity to be 
established through the multiple bond correlations of the diketopiperazine amide protons. 
 
A section of the TOCSY spectrum of 2.  Note the correlations to 10H, where correlations are seen to protons on both 
C11 and C12.  This is an example of one full spin system showing correlations between all members, not just those 
atoms within three bonds as is observed in COSY-type experiments. 
Figure 30.  TOCSY Spectrum of 2 
 
The assignment of all H-C correlations within individual residues was accomplished 
through the portions of the HMBC spectrum shown in Figure 31a and Figure 31b and modeled in 
Figure 32c (full spectra included in Appendix).  The spectra in Figure 32a and Figure 32b show 
the correlations of the diketopiperazine amide bonds.  As can be seen in in the three dimensional 
rendering of 2 in Figure 32c, each amide proton contained within the diketopiperazine rings was 
correlated to at least four carbon atoms, for example the N8 proton was correlated to C5, C9, 
C10 and C16.  The C5 and C16 carbon atoms were contained in the pip5(2S5R) monomer, while 
the C9 and C10 carbon atoms were contained in the pip5(2R5S) monomer.  By combining the 
assignment of the correlations within the monomer residues with the correlations of the amide 
protons in the diketopiperazine linkages, network of C-H correlations could be established for 2 
from C1 throughout the molecule and into the tyrosine ring (Figure 33).  This network of 
connections assigned all carbon and hydrogen resonances with 2, but did not allow the 
assignment of diastereotopic protons. 
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A.) 
 
 
 
 
 
 
 
  B.)   
 
 
 
  
 
 
 
 
C.) 
 
 
 
A.) Section of the HMBC spectrum of 2 highlighting the methylene region of the spectrum.  B.) Section of HMBC 
spectrum of 2 highlighting the carbonyl region of the spectrum.  C.)  Overlay of intra-residue HMBC correlations 
with theoretical model. 
Figure 31.  HMBC  Spectra Showing Intra-residue Connectivity 
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B.) 
 
 
 
 
 
 
 
 
 
C.) 
   
   
 
A and B)  Sections of  HMBC spectrum of 2 highlighting inter-residue correlations.  C.) Overlay of inter-
residue HMBC correlations with theoretical model. 
Figure 32.  HMBC Spectra Showing Inter-residue Connectivity 
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Figure 33.  Network of HMBC Correlations used to Assign the 1H and 13C Resonances of 2 
4.10 ASSIGNMENT OF THE DIASTEREOTOPIC PROTONS ON METHYLENE 
GROUPS 
The assignment of the methylene protons within 2 was accomplished using ROESY 
spectroscopy and the absolute stereochemistry of each monomer, which was established in the 
synthesis of 2.  The known stereochemistry within the monomers was used to assign correlations 
in the ROESY spectrum (Figure 34a) to the geminal methylene hydrogen atoms of each 
piperidine or pyrrolidine ring in 2 (Figure 34b).  Figure 35 shows the pip5(2S5R) monomer of 2 
with ROESY correlations from the N8 amide proton overlaid. From the pip5(2S4R) monomer 
stereochemistry, we knew that the diketopiperazine amide hydrogen atom on N8 was on the 
same face of the piperidine ring as the hydrogen atom on C2.  Strong correlations were observed 
between the N8 hydrogen atom and only one hydrogen atom each on C6 and C4 (Figure 35).  
We inferred that this C6 hydrogen atom was on the same face of the piperidine ring as the N8 
hydrogen atom, and it was termed C6Ha; the correlated geminal C4 hydrogen atom was assigned 
to the same face of the ring and was termed C4Ha.  One C3 hydrogen atom was observed to have 
a weak correlation to the N8 hydrogen atom leading us to assign it to the same face as C6Ha and 
C4Ha.  A similar network of ROESY correlations between the geminal hydrogen atoms on the 
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monomer rings and the amide hydrogen atoms of the diketopiperazine rings, or the correlations 
between the geminal hydrogen atoms and the hydrogen atom on either C10 or C19, were used to 
assign all of the methylene hydrogen atoms within 2. 
  
A.)                                                                              B.) 
  
A) ROESY spectrum of 2  B.) ROESY correlations of the diketopiperazine amide hydrogen atoms and methylene 
hydrogen atoms in 2 are overlaid on the lowest energy conformer of 2 as predicted by the AMBER 94 force field. 
Figure 34.  ROESY Spectrum and Overlay of Certain Correlations with a Model of 2  
 
 
 
Figure 35.  Overlay of ROESY Correlations with Pip4(2S5R) Monomer in 2  
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Figure 36.  ROESY Correlations Overlaid with Pip4(2S5R) Monomer in 2 
 
 
Figure 37.  ROESY Correlations Overlaid with Pip4(2R5S) Monomer in 2 
 
Figure 38.  ROESY Correlations Overlaid on a Model of the Pro4(2S4S) Monomer in 2 
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4.11 DETERMINATION OF THE CONFORMATION OF 2 BY ROESY 
SPECTROSCOPY 
With the methylene hydrogen atoms assigned, the shape of the molecule could be 
interpreted from the intra and inter-residue ROESY correlations by comparison with model 
structures.  The comparison of ROESY correlations with MOE/AMBER 94 derived conformers 
of 2 was undertaken to determine which conformer was most consistent with the NMR data. 
A correlation between the C2 hydrogen atom and C6Ha in the ROESy spectrum of 2 
(Figure 36) were interpreted as indicating a 1,3 diaxial relationship between these protons.  The 
C6Ha and C4Ha hydrogen atoms were correlated in the spectrum and were interpreted to be 
diaxial.  This observation was consistent with the piperidine ring of the pip5(2S5R) residue 
residing in the chair conformation shown in Figure 36.  Similarly, a network of correlations 
between the C10 hydrogen atom with one each of the geminal C12 and C14 protons indicated the 
chair conformation for the pip5(2R5S) monomer as shown in Figure 37. 
The conformation of the pro4(2S4S) residue was inferred using the correlation of C19H 
with C22Ha to be the conformation displayed in Figure 38.  ROESY correlations between the 
aryl protons of the tyrosine residue and both C22 protons indicated that the aromatic ring was 
rotated to be in proximity to C22 of the pro4(2S4S) monomer (Figure 39). 
 
A.)                                                                                B.) 
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A.)  A section of the ROESY spectrum of 2 demonstrating the interactions of the tyrosine aryl protons with the 
protons on C22.  B.)  An overlay of the ROESY interactions with the lowest energy conformer of 2. 
Figure 39.  ROESY Spectrum Section Showing Tyrosine Interactions with C22 Protons 
 
4.12 CONCLUSIONS 
 The conformer of 2 found to be most consistent with the NMR data was the conformer 
predicted by MOE/AMBER 94 to be the thermodynamically favored structure (Figure 40), and  
was consistent with previous data collected on other bis-peptides5,6. 
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Figure 40.  Solution Phase Structure of 2 Determined by ROESY Spectroscopy 
 
   The data was most consistent with the pip5 monomers preferring a chair conformation 
that places the methine proton of the piperidine ring in a pseudo-axial position.  This 
conformation limits the 1,3-diaxial interaction between the carbonyl group attached to the 
methine carbon and axial protons within the monomer ring.  As an example, the C2 hydrogen 
atom of the pip5(2S4R) monomer is in the axial position in the solution phase structure of 2. 
 The limitation of the use of only ROESY correlations to determine a solution structure is 
highlighted by the interpretation of the pro4(2S4S) residue pyrrolidine ring conformation.  Only 
one ROESY correlation was available from the spectrum to interpret the conformation of the 
pyrrolidine ring.  The use of residual dipolar coupling could determine additional constrains on 
the conformation of this ring allowing a greater confidence in the conformational assignment.  
 Bis-peptide oligomer 2 was designed to contain a tight curve that placed the ends of the 
oligomer in close proximity.  The solution phase structure we have determined for 2 contains just 
such a tight curve.  Our determination of the curved conformation of 2 has led us to further 
investigate the potential catalytic properties of this molecule, as the close proximity of the two 
ends of the oligomer may allow its use as a scaffold for bifunctional catalysis. 
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4.13 EXPERIMENTAL METHODS 
Example of preparation of Pro4SS-Pro4RR-Pro4SS-Tyr (1) 
Rink Amide AM resin (Novabiochem, 200-400 mesh, 0.63 mmol/g loading), 33.1 mg, 
was swollen in DMF overnight.  The resin was washed with DMF three times and Fmoc 
deprotected with a solution of 20% piperidine in DMF for 30 minutes. The resin was washed, for 
five minutes each step, twice with DMF, twice with isopropanol, three times with DMF and once 
with DCM.  Preactivation of the Pro4SS monomer (2 eq with respect to resin loading) was done 
with 2 eq. O-(7-Azabenzotiazol-1-yl)-N,N,N’,N’-tetramethyluronium hexafluorophosphate 
(HATU) (Aldrich) and 4eq. diisopropylethylamine (DIPEA) in 330 μL of 20%DCM in DMF for 
five minutes before introduction to the resin.  The coupling solution was allowed to react with 
the resin bound amine for 1 hour. The resin was washed according to the procedure above, and 
the coupling procedure was repeated with the same monomer. 
After washing the resin, Fmoc deprotection was done with 20% piperidine in DMF.  The 
resin was again washed as above and the next residue, Pro4RR, was coupled to the resin as 
above.  This was repeated until the sequence had been formed. 
After the terminal tyrosine residue was coupled, the resin was Fmoc deprotected and 
washed with DMF, acetic acid, DCM, methanol, DCM, then methanol.  Drying of the resin was 
accomplished by placing it under vacuum overnight.  Cleavage of the dried resin was performed 
with 95% trifluoroacetic acid (TFA), 2.5% triispropylsilane, and 2.5% water (total volume 1 mL) 
for two hours.  The cleavage solution was removed and the resin washed with additional TFA.  
The combined cleavage solution and wash solution was dried down to solid with a stream of dry 
N2. 
The residue was dissolved in 1 mL of 20% piperidine in 1-methyl-2-pyrrolidinone (NMP) 
and was incubated for 3 days at room temperature to allow closure of the diketopiperazine rings.  
Closure was monitored by LCMS with a one-half hour gradient of 0-25% acetonitrile in water 
with 0.1% formic acid added.   
After closure was complete the NMP solution was diluted in 40 mL of diethyl ether to 
precipitate the product.  Centrifugation at 3200 RPM for 30 min. concentrated the precipitate, 
allowed the ether to be decanted from the tube and the precipitate to be dissolved in 1 mL of 
water with 0.1% TFA added.  This solution was HPLC purified on a Varian Pro Star Preparatory 
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HPLC system with an Xterra Prep MS C18 5 μm diameter column (6.5 mL/min flow rate, 0-25% 
gradient over 30 minutes of acetonitrile in water with 0.1% formic acid added) and dried down to 
a white powder in a Savant Speed Vac SC110.  The yield of product was determined by UV 
absorbance of the tyrosine residue at 274 nm to be 10.2 μmol (48.8% yield based on resin 
loading).  HRMS –Q-Tof : [M+H]+ calcd for C27H31N8O8 595.2265; found 595.2268. 
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NMR Sample preparation for complete assignment  
 A portion of the sample was brought up in 400 uL of 20 mM acetate buffered 
10% D2O in H2O ( pH 3.49) and placed in a Shigemi NMR tube for spectral collection.   An 
aliquot of 2 μL from the NMR sample was diluted up 50 μL and tested for absorbance at 274 
nm.  The concentration of the sample was 8.5 mmol/L.  This sample  was used to establish the 
identity of individual resonances through HMBC, TOCSy and ROESy experiments obtained at 
277 K on a Bruker DRX 600 MHz instrument. 
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Example Spectra of Assignment 
TOCSy 
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ROESy 
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HMBC 
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Unaligned NMR sample preparation (F2 coupled) 
 A portion of the sample was brought up in 350 uL of 50 mM phosphate buffered D2O 
(pD 7.49) and placed in a Shigemi NMR tube.  The analyte concentration of this sample was 4.6 
mM.  This sample was used to determine the 1JCH coupling constants as measured in the F2 
dimension of an HSQC experiment on a Bruker 800MHz NMR with a cryoprobe and sample 
temperature of 298 K.  The data was collected at 16K data points in the F2 dimension and 256 
points in the F1.  The introduction of coupling was achieved by setting the decoupling pulse 
strength during signal acquisition to 120 dB. 
 
Dialysis of phage  
 Pf1 Magnetic Resonance Cosolvent Solution (pf1 phage 54mg/ml in 10 mM phosphate 
buffered H2O, pH 7.6) was purchased from Asla Biotech.  To obtain aligned spectra in D2O, 
samples of the phage solution were dialyzed with pD 7.49 50 mM phosphate buffered D2O.  200 
μL of the supplied phage solution was placed in a Millipore Biomax 10K NMWL Membrane 
Filter and diluted to 1.5 mL with buffer.  The filtration device was placed in a 40 mL Falcon tube 
and Centrifuged at 3200 rpm for 4 hours.  The residual phage was resuspended with an 
additional 1.5 ml of buffer and centrifuged for four hours.  The residual phage was diluted with a 
volume of buffered D2O sufficient to give a 50 mg/ml solution.  Final concentration of phage 
was determined by UV absorbance at 270 nm and was found to be 45.5 mg/mL.  
 
Aligned NMR sample preparation (F2 coupled) 
 An amount of dialyzed phage solution sufficient to achieve a 10 mg/ml solution of phage 
(98 μL) was added to the 350 μL sample of analyte to give a 3.6 mM analyte concentration and a 
second F2 dimension coupled HSQC spectrum was collected at 298 K (16K data points F2, 256 
F1).   
 
 
Collection of F1 coupled HSQC spectra 
 The deletion of the 180 degree, 1H channel pulse during the incremented delay period 
allowed for 1JCH coupling values to be viewed in the F1 (carbon) dimension of the spectrum. A 
sample of the trimer was dissolved in 350 μL of 50 mM phosphate buffered (pD 7.49) D2O.  
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This sample was determined to be 4.2 mM in analyte. The HSQC spectrum was obtained on a 
Bruker DRX 600MHZ instrument equipped with a cryoprobe and a sample temperature of 298K.  
The spectrum was collected with 4K data points in the F2 dimension and 2K data points in the 
F1 dimension. For methine groups the splitting was equivalent to the 1JCH value, while for 
methylene groups the splitting was equivalent to the sum of both 1JCH values.   
 Deuterium oxide dialyzed phage alignment media, 76 μL of 45.5 mg/mL concentration 
was added to this sample to give a final analyte concentration of 3.4 mM and a phage 
concentration of 10mg/mL.  This sample was used for the measurement of the summed 1JCH and 
1DCH values.   
 
 
Group Atom Nuc 
Chemical 
Shift 
1 C 13C 172.85 
18 C 13C 170.366 
29 C 13C 170.094 
26 C 13C 168.334 
9 C 13C 168.131 
24 C 13C 166.182 
16 C 13C 165.397 
34 C 13C 154.764 
32 C 13C 131.363 
31 C 13C 125.516 
33 C 13C 115.548 
19 C 13C 57.519 
2 C 13C 56.722 
10 C 13C 55.478 
27 C 13C 55.33 
13 C 13C 54.852 
22 C 13C 53.864 
5 C 13C 51.924 
20 C 13C 51.643 
6 C 13C 47.426 
14 C 13C 44.766 
30 C 13C 37.772 
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4 C 13C 33.104 
12 C 13C 32.205 
11 C 13C 25.839 
3 C 13C 22.981 
28 H 1H 8.799 
25 H 1H 8.736 
8 H 1H 8.702 
17 H 1H 8.517 
32 H 1H 7.055 
33 H 1H 6.918 
14 HB 1H 4.814 
19 H 1H 4.765 
27 H 1H 4.485 
10 H 1H 4.194 
6 HB 1H 3.858 
2 H 1H 3.799 
30 H2 1H 3.227 
6 HA 1H 3.137 
30 H1 1H 2.952 
22 HB 1H 2.766 
14 HA 1H 2.747 
20 HA 1H 2.715 
12 HB 1H 2.425 
4 HB 1H 2.404 
22 HA 1H 2.313 
3 HA 1H 2.293 
3 HB 1H 2.263 
11 HA 1H 2.248 
20 HB 1H 2.144 
4 HA 1H 1.928 
12 HA 1H 1.879 
11 HB 1H 1.773 
    All values are relative to TMS 
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    Pro4ss-Pro4rr-Pro4ss-Y 
Group Atom Nuc Shift 
2 C 13C 170.314
28 C 13C 170.055
17 C 13C 169.719
25 C 13C 168.392
23 C 13C 166.442
15 C 13C 165.119
31 C 13C 131.486
32 C 13C 125.297
5 C 13C 63.996 
12 C 13C 61.319 
20 C 13C 59.596 
3 C 13C 59.171 
10 C 13C 57.775 
18 C 13C 57.596 
26 C 13C 55.461 
13 C 13C 54.786 
21 C 13C 54.276 
6 C 13C 52.887 
19 C 13C 39.988 
4 C 13C 37.863 
29 C 13C 37.825 
11 C 13C 36.584 
27 H 1H 8.85 
8 H 1H 8.793 
16 H 1H 8.786 
24 H 1H 8.771 
1 HN2 1H 8.134 
1 HN1 1H 7.55 
31 H 1H 7.059 
32 H 1H 6.91 
10 H 1H 4.905 
18 H 1H 4.782 
3 H 1H 4.745 
26 H 1H 4.479 
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13 HA 1H 3.95 
6 HA 1H 3.911 
13 HB 1H 3.863 
6 HB 1H 3.627 
29 H2 1H 3.229 
4 HA 1H 3.209 
29 H1 1H 2.949 
11 HA 1H 2.906 
19 HA 1H 2.748 
21 HB 1H 2.732 
21 HA 1H 2.38 
11 HB 1H 2.341 
4 HB 1H 2.288 
19 HB 1H 2.162 
    All values are relative to TMS 
4.2 
 Synthesis of 4.2 was performed by Christopher Morgan 
NMR Sample preparation for complete assignment  
 2 was dissolved in 400 uL of 20 mM acetate buffered 10% D2O in H2O ( pH 3.49) and 
placed in a Shigemi NMR tube for spectral collection.   An aliquot of 2 μL from the NMR 
sample was diluted up 50 μL and tested for absorbance at 274 nm.  The concentration of the 
sample was 10.3 mmol/L.  This sample was used to establish the identity of individual 
resonances through HMBC, TOCSy and ROESy experiments obtained at 277 K on a Bruker 
DRX 600 MHz instrument. 
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